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Preface
The widespread availability and use of methamphetamine in Southeast Asia has been a very real 
concern for families, communities, and affected States. Methamphetamine and related substances 
can lead to a range of harms for individual users, their loved ones, and their communities. So 
it should not be surprising that governments in the region have attempted to respond to rising 
methamphetamine use, or that they have sought, and received, donor support to do so. 
How have the governments of Thailand, Laos, and Cambodia responded? 
As this report details, the prevailing responses have been compulsory detention—generally 
without medical management of detoxiﬁcation. Detention in conditions that are themselves threats 
to health and life, has been done under the banner of “treatment” for drug use, but little or no 
evidence-based treatment has been available. 
The voices of drug users heard here are among the ﬁrst to have emerged from these 
Southeast Asian “compulsory drug treatment/detention centers (CDTDCs).” They will remind 
many readers of the accounts of mental patients from 18th or 19th century Europe—with shackles, 
chains, and beatings masquerading as treatment, gross overcrowding, the ever-present stench of 
human waste, and the always dangerous mix of locking away children and youth with adults. That 
men and women, adolescents and adults, are being detained across this region in dangerous and 
destructive environments without due process, often without trial, and based on arbitrary decisions 
by untrained ofﬁcials, makes this all the more a cause for regional and international concern. 
This report makes clear that drug treatment is not occurring in these compulsory centers, 
and that what is happening to thousands of (mostly young) people is a threat to public health and 
safety, and represents ongoing violations of a range of basic human rights. Anxiety over drug abuse 
leads many governments to respond with harsh and draconian measures, often to little avail. But 
here we see governments, and well-meaning individuals within them, attempting to address a 
problem with solutions that are profound failures on any measure we have. This must stop.
How can the governments of Thailand, Cambodia, and Laos respond to methamphetamine 
use in ways that might actually help affected citizens and their families and deal with the social 
and security concerns over methamphetamine use? The authors suggest several steps that should 
be undertaken immediately. First, halt the construction of more CDTDCs. To date, there is only 
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evidence of their harm. Second, invest in community-based strategies that can better address the 
harms of methamphetamine use. And ﬁnally, transition to community-based models of drug treat-
ment and initiate the closing down of all CDTDCs. 
The donor community, including the United Nations, has critical roles to play as well. Given 
the evidence of the harms of these compulsory detention facilities, and the lack of evidence for their 
efﬁcacy, donors should cease and desist from ﬁnancial support for these institutions. Continuing 
to support these centers now that we know about the kinds of abuses they are leading to, including 
the incarceration and sexual exploitation of minors, could be tantamount to complicity in rights 
violations, or at least to the perceived tolerance of those violations. 
Donors could play truly positive roles by promoting, piloting, and helping to evaluate alter-
native approaches to compulsory detention. Normative guidelines on drug treatment based on 
evidence and grounded in human rights would be enormously helpful as well. Arbitrary and 
compulsory detention is not drug treatment. And the ways in which it is now being conducted in 
Thailand, Cambodia, and Laos is inhumane, ineffective, and must change. 
This report sheds critical and much-needed light on hidden and neglected people who need 
our urgent attention. Please read it, and please act on its ﬁndings and recommendations.
Sincerely,
Chris Beyrer, MD, MPH
Director, Center for Public Health and Human Rights 
Johns Hopkins Bloomberg School of Public Health
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Executive Summary
This report examines the establishment and operation of centers to detain and “treat” metham-
phetamine users in Thailand, Cambodia, and Laos. It documents the increasing number of such 
compulsory drug treatment/detention centers (CDTDCs)1, examines the policies and practices 
that force people into them, and explores the implications for individual health, public health, and 
human rights. This approach to treating methamphetamine use is implemented without evidence 
of effectiveness, and it places people in environments where their basic health needs are unmet 
and abuse is pervasive.
The core issue identiﬁed in this report is the use of law enforcement approaches to address 
health issues. Though drug policies in Thailand, Cambodia, and Laos have been amended in recent 
years to recognize that drug dependence is a health issue, the public security sectors in these three 
countries tend to trump the smaller and weaker health sectors. Illicit drug use remains a violation 
of criminal law in these countries, and people who use drugs are treated as criminals. CDTDCs 
are generally run by police or military personnel. Drug users are often detained using administra-
tive rules rather than criminal laws, and in many cases, do not see a judge or have the ability to 
question or appeal internment.
International actors, particularly agencies of the United Nations and donor states, face a 
policy conﬂict when confronted with CDTDCs. At the same time that they advocate for evidence-
based treatment, they issue grants to agencies working with these centers or to the centers them-
selves. The steady growth in the construction of the CDTDCs, and the lack of HIV prevention or 
treatment, evidence-based and effective drug treatment, or any other medical treatment, reveal 
the limits of the approach. 
While opiate users comprise the majority of those detained in CDTDCs in countries like 
China and Vietnam, in many countries in Southeast Asia it is methamphetamine users who are 
the overwhelming majority of detainees. The production, trafﬁcking, and use of methamphet-
amine in Thailand, Cambodia, and Laos pose signiﬁcant challenges to both the law enforcement 
and health service sectors. As with other problems related to illicit drugs, ﬁnding an appropriate 
balance between the security needs of the community and the health needs and rights of meth-
amphetamine users should be the ultimate goal. The current approach, however, is harmful to the 
health and rights of individuals, and to the health of the larger community. 
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Patients Not Criminals: Rhetoric versus Reality
In each of the three countries considered in this report, it is speciﬁed, either by law or Prime 
Ministerial Decree, that methamphetamine users are to be considered patients, not criminals. 
Considering the multiple and ongoing violations of human rights of methamphetamine users in 
Thailand, Cambodia, and Laos, it is hard to argue that detained individuals are in fact treated like 
patients. Placing methamphetamine users in compulsory detention is possibly the worst interven-
tion imaginable, given their health-related risk proﬁles and needs. Instead they require a range of 
services that focus on sexual risk behaviors and drug use in their community and social networks. 
These centers lack health professionals and staff are not trained in drug dependence treat-
ment; individuals detained in these centers are not provided with pre-admission or pre-release 
health screenings (including mental health), or post-release support. Additionally, methods of 
detention are not conducive for effective treatment: these include use of chains and locking groups 
of people in rooms that resemble large holding cells.2 The settings are far more basic in Laos and 
Cambodia, where youth and adults are conﬁned in much smaller cells, generally with no mat-
tresses on the concrete ﬂoors.3 In Cambodia, the government is quite open in acknowledging the 
obvious pitfalls of these CDTDCs and suggests that:
 “…due to the lack of a structural mechanism between the Ministry of Interior 
and the Ministry of Health there is no mechanism that would provide and make 
available essential medicines at this stage.”
4
People who use drugs in Thailand, Cambodia, and Laos are breaking national laws and are 
therefore, in many cases, treated like criminals. This does not mean, however, that the state has a 
right to deprive these people of appropriate medical treatment. In fact the due process and health 
rights of people in detention are guaranteed under international law, particularly the International 
Covenant on Civil and Political Rights (ICCPR),5 and in Article 12 of the International Covenant 
on Economic, Social and Cultural Rights—“the right of everyone to the enjoyment of the high-
est attainable standard of physical and mental health”—both of which all three countries have 
ratiﬁed.6 In regard to detained persons, the United Nations Basic Principles for the Treatment 
of Prisoners further adds that: “Prisoners shall have access to the health services available in the 
country without discrimination on the grounds of their legal situation.”7 
Infectious Disease
Not only do detainees receive inadequate treatment in the CDTDCs8; they are also placed in situ-
ations where their health is put at greater jeopardy. Several studies have shown that people placed 
into detention settings are at signiﬁcantly greater risk of contracting infectious diseases, including 
HIV, tuberculosis, hepatitis C, and skin infections. These health threats can follow detainees back 
to their home community upon release. 
Risky sexual behavior, both predatory and consensual, occurs in the CDTDCs in Laos and 
Cambodia. In Thailand, methamphetamine users are detained in prisons prior to internment in 
CDTDCs. The detention of young people in CDTDCs, and in many cases the detention of juve-
niles with adults, poses signiﬁcant risks for HIV acquisition particularly since detention increases 
sexual exploitation. Furthermore, other HIV risk behavior such as tattooing and body piercing are 
prevalent in these settings. 
Arbitrary Arrest and Detention
When any person is removed from society and placed in a custodial setting, there should be proper 
legal safeguards and procedures to guarantee the rights of the detainee. This right is guaranteed by 
Article 9.4 of the ICCPR that states that any person “deprived of his liberty by arrest or detention 
shall be entitled to take proceedings before a court, in order that that court may decide without 
delay on the lawfulness of his detention and order his release if the detention is not lawful.”9 The 
UN Human Rights Committee has interpreted this provision to apply to “all deprivations of liberty, 
whether in criminal cases or in other cases such as, for example, ... drug addiction...”10
One means for detention, in Laos and Cambodia, appears to be a signed contract between 
parents or guardians of the detainee and the CDTDC in which they are detained. In most cases, 
young people and adults alike are rounded up by police and incarcerated at a CDTDC without any 
legal review of the evidence of drug use, abuse, addiction, or perceived harm of the individual to 
the community. 
In Thailand, regulations allow for those suspected of being in possession of or using meth-
amphetamine to be detained in prisons for up to 45 days11 pending the case review by a committee 
that is both under-funded and overworked. Furthermore, many young methamphetamine users 
spend a signiﬁcantly longer period of time in prison before being sent to a CDTDC, if they are in 
fact ever transferred at all. 
 
Evidence-based and Voluntary Drug Treatment 
People who use drugs should have access to voluntary treatment programs that are based on 
evidence of effectiveness. In many cases, methamphetamine users in CDTDCs are detained 
against their will for an open-ended period of time. Considering that regionally relevant research 
found that an acute phase of methamphetamine withdrawal usually only lasts a couple of days 
and a sub-acute phase between seven and 15 days,12 detaining people for anywhere between several 
months and three or four years has no basis in evidence. There have been no formal evaluations 
as to the effectiveness of the CDTDCs in reducing return to methamphetamine use upon release. 
All the anecdotal evidence suggests that upon release from the CDTDCs, the relapse rates are 
extremely high. This means that people do not get better in these CDTDCs and in many cases, 
actually get worse. 
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Without an investment in community-based and individualized interventions, large num-
bers of methamphetamine users in Thailand, Cambodia, and Laos are likely to continue to move 
between prisons, CDTDCs, and their communities, thereby increasing their own and their sexual 
partners’ risk for acquisition of blood-borne pathogens, sexually transmitted infections (STIs), and 
other communicable diseases. Furthermore, they are likely to have their human rights violated and 
spend a signiﬁcant part of their youth behind bars.
Key Recommendations
To the Governments of Thailand, Cambodia, and Laos 
• Immediately halt construction of new CDTDCs. 
• Investigate ill treatment in CDTDCs, hold violators accountable, and cease all state 
activities and practices that perpetuate the criminalization of people who use drugs.
• Invest in community-based strategies that address the harms associated with the use 
of methamphetamine (such as programs to deter risky injection practices and STI 
prevention, screening, and treatment). 
• Devise national strategies to close down all CDTDCs and transition to community-
based models of treatment.
• Release all those currently detained in CDTDCs, as their detention is unjustiﬁable, 
even in the absence of viable treatment options in the community.
To the United Nations and Donor Community
• Immediately cease any ﬁnancial support to the building of new CDTDCs or mainte-
nance of existing CDTDCs in Thailand, Cambodia, and Laos. Review programs and 
polices inside the centers to ensure they’re not furthering human rights abuses.
• Promote, pilot, and evaluate community-based alternatives to CDTDCs for the treat-
ment of methamphetamine and the integration of associated health and social ser-
vices. 
• Develop regional guidelines on appropriate treatment for those that require treatment, 
and harm reduction approaches to methamphetamine that are both evidence-based 
and grounded in human rights. 
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Introduction
A meeting at the 18th International Harm Reduction Association conference in Warsaw in 2007 
sparked the genesis of this report. At that meeting, various people from United Nations agencies 
and international human rights groups discussed the issue of drug treatment and the need for 
the promotion of evidence-based, voluntary drug treatment grounded in fundamental human 
rights principles. Participants felt that the UN needed to take a greater lead to ensure that rights 
violations in the name of drug treatment would cease. During that meeting, participants raised 
the issue of young methamphetamine users in CDTDCs in Thailand, Cambodia, and Laos. They 
expressed concerns that CDTDCs operated contrary to fundamental human rights principles and 
were being built at an exponential rate—in some cases, with support from UN agencies or donor 
nations. UN ofﬁcials replied that they felt there was insufﬁcient evidence to justify such claims 
and that more careful documentation was needed in order for anything to be done about the situ-
ation. With this report, and others recently published, human rights violations in CDTDCs can 
no longer be denied.
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Methodology
Between June 2008 and October 2009, 30 interviews were conducted at various levels with gov-
ernment ministries, UN agencies, and nongovernmental organizations (NGOs) from Thailand, 
Cambodia, and Laos. Participants were selected because they either worked in ministries or depart-
ments that oversaw the compulsory drug treatment system, worked with methamphetamine users, 
or worked as staff at CDTDCs. Interviews focused on the source of funding for the CDTDCs, the 
costs of management of the CDTDCs, the centers’ effectiveness in preventing recidivism to drug 
use, the prevalence of HIV risk behaviors in the CDTDCs, and the implications of the CDTDCs 
for public health and human rights. In addition, participants were asked for their ideas and sug-
gestions for how to improve treatment for methamphetamine users. Some participants offered 
their insights through off-the-record conversations or through email exchanges. 
During the same time period, interviews were conducted with 30 recently released detainees 
from CDTDCs in Thailand, Cambodia, and Laos. Interviewers had initial access to participants 
either through their work with research institutes and NGOs, or through their social networks. 
Once the initial participants were recruited, respondent-driven sampling was used to recruit fur-
ther participants. A semi-structured interview guide was designed to elicit key information from 
participants relating to aspects of their time in CDTDCs including the circumstances of admission, 
the cost of being in the CDTDCs, the medical treatment provided, treatment by the center staff, 
the living conditions, and availability of HIV prevention. None of the people approached for this 
set of interviews declined to participate. 
Interviews were conducted by local, trained interviewers who were familiar with the sub-
ject matter. Interviews were recorded on tape where possible, transcribed, and then translated. 
When it was not possible to tape interviews, extensive notes were taken that were transcribed and 
translated immediately following the interview. Translated interviews were discussed and checked 
for accuracy by two people ﬂuent in both languages, prior to analysis. Up to ten interviews were 
conducted with individuals who had spent some period of time in a CDTDC in each country until 
saturation of information was reached. 
Due to the sensitive nature of the information, identifying information for many of the 
interviewees, both ofﬁcials and recently released detainees, has been omitted.
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In addition to interviews, information came from an extensive literature review of published 
and unpublished papers and reports, and through the use of relevant internet sources. Where 
possible, information has been veriﬁed by at least one other source. 
Background 
The Continued Increase of Methamphetamine Use in 
Thailand, Cambodia, and Laos 
Experts have linked the rise of methamphetamine production, trafﬁcking, and use in Thailand 
and Southeast Asia to the Asian economic crisis of 1996,13 the collapse of the infamous Khun Sa 
heroin operations in Burma,14 ongoing internal conﬂicts in Burma, transnational crime syndicates, 
and the shifting trends of global illicit drug use. In reality, the rise of methamphetamine use in 
Southeast Asia is most likely the result of all of these and a host of other social and environmental 
factors.
Whatever the cause, there has indeed been an exponential increase in the recreational use 
of methamphetamine in Thailand, Cambodia, and Laos since 1996. In fact, methamphetamine 
has surpassed heroin as the major drug used15 in many parts of the Southeast Asian region. 
In Thailand, the ﬁrst country where increases in methamphetamine use were carefully docu-
mented,16 there has also been a documented rise in adverse health and social consequences related 
to methamphetamine use. This has been seen in Cambodia and Laos as well. These consequences 
include high rates of common STIs among methamphetamine users,17 high rates of self-reported 
depression and alcohol consumption,18 psychosis,19 and deleterious interactions with law enforce-
ment ofﬁcials that often result in some period of incarceration in either prison, a CDTDC, or 
both.20, 21
Between 1955 and 1980, methamphetamine tablets, known in Thailand as “yaba” and in 
other parts of the region as “yama,”22 were initially legally available23 and ingested by laborers in 
Southeast Asia to provide additional energy for physical work.24 Large-scale production of yaba 
tablets continues in the region, predominantly in Burma, but also throughout Thailand, with 
recent reports of production in Cambodia,25 and anecdotal reports of production in Laos.26 With 
an increased supply and deliberate marketing campaign, methamphetamine tablets became the 
most common recreationally used illicit drug in Thailand by 1997 and are currently the most 
used illicit drug in Laos and Cambodia among young people.27 Methamphetamine tablets vary 
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in chemical composition, but in general contain approximately 25 percent active methamphet-
amine.28 In addition, the amphetamine-type stimulant known as “ice” (a crystalline form of meth-
amphetamine) is becoming increasingly produced, trafﬁcked, and used in Southeast Asia.29 
Methamphetamine and ice are typically inhaled. The tablets or crystals are often put on foil 
and melted from beneath. The resulting vapor is either inhaled through water or directly through 
a straw. The documented effects include feelings of euphoria, alertness, and conﬁdence,30 but 
these are often followed by feelings of anxiety, depression, and insomnia; in some, prolonged use 
leads to acute psychosis31, 32 (see Annex 1 for more information about methamphetamine use). In 
2003, Thailand’s Academic Substance Abuse Network33 estimated that 3,500,000 citizens had ever 
used methamphetamine.34 Though estimates vary widely, some researchers suggest that, among 
the estimated 520,000 drug users in Cambodia, methamphetamine tablets are the predominant 
drug of abuse.35 In Laos, there are no reliable estimates of the total number of illicit drug users, 
but the Laos government has said that the use of methamphetamine is the most pressing illicit 
drug concern in the country.36 In 2008, a United Nations Ofﬁce on Drugs and Crime (UNODC) 
study estimated that there were between 35,000 and 40,000 methamphetamine addicts in Laos37 
but did not specify how the term “addict” was applied.
Figure 1. Traditional, emerging, and expanding methamphetamine trafﬁcking routes 
across Southeast Asia and into South Asia (2002)
Source: UNODC East Asia and the Paciﬁc
The Thai government began criminalizing methamphetamine in 1996.38 In 2003, the gov-
ernment launched a well-documented “war on drugs” that included mass arrests of those suspected 
of manufacturing or selling methamphetamine, as well as what human rights observers termed 
extrajudicial executions of more than 2,500 individuals, often following police interrogation.39 In 
combination, these events led to a doubling of the number of people incarcerated in Thailand’s 
prison system between 1996 and 2004.40 In 2006, 75 percent of the 68,000 drug-related charges 
in Thailand were related to methamphetamine;41 this number rose to 84,073 methamphetamine-
related arrests in 2007.42 Thailand’s Department of Corrections’ website states that offences associ-
ated with narcotics currently account for 55 percent of all incarcerations.43 In Cambodia, more than 
90 percent of people charged with drug law violations in 2005 and 2006 were charged in relation 
to methamphetamine tablets. In Laos, 100 percent of drug-related arrests in 2006 were attributed 
to methamphetamine tablets. In all three countries more than 75 percent of those arrested on 
drug-related charges are male.44
Risk Proﬁles of Methamphetamine Users 
A recently completed ﬁve-year study investigating risk proﬁles and peer-based risk reduction strate-
gies with methamphetamine users in northern Thailand45
 
showed that methamphetamine users 
between the ages of 18 and 25 (n=1,189) had multiple risks for problems of substance use, STIs, 
HIV, mental illness, and criminal records. The cohort were frequent users of methamphetamine 
tablets; in addition, 50 percent reported alcohol abuse more than ﬁve days a week; chlamydia 
rates were above 30 percent; 22 percent had ever been arrested and of those, 75 percent had been 
arrested at least twice; condom use during the most recent sexual intercourse was only 15 percent; 
and many females reported unplanned pregnancies and self-induced abortions.46 
The results of a similar study conducted in Thailand, Cambodia, and Laos were presented 
at the International Harm Reduction Association conference in Bangkok in April 2009.47 Initial 
exploration of data from those countries suggests that the risk proﬁles of young methamphetamine 
users are fairly similar in all three countries, including high rates of STIs (three to six times higher 
in women than men); and high arrest rates for methamphetamine users who were not already in 
a CDTDC (20 percent in Laos, 40 percent in Cambodia, and 34 percent in Chiang Rai, Thailand). 
The primary reason for arrest was for using methamphetamine or ﬁghting, with less than ﬁve 
percent arrested for selling or delivering drugs. 
Methamphetamine users in this study reported similar alcohol and sexual risk proﬁles as in 
the Chiang Mai study. While the non-injecting use of methamphetamine does not carry the same 
risk of HIV acquisition as injecting drug use, it appears that non-injecting methamphetamine 
users have more risk of HIV through sexual behavior compared to other sentinel groups studied 
in the region48 (see Annex 2 for more information on a peer-based intervention study conducted 
with methamphetamine users in northern Thailand).
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Assessment, Management, and Treatment of 
Methamphetamine Dependence
The physical manifestations of methamphetamine use include a loss of appetite, insomnia, rapid 
heartbeat, jaw tension, grinding of teeth, palpitations, irritability, desire to urinate, and tremors.49 
Adverse psychological consequences of methamphetamine use are usually short-lived, typically 
lasting a few hours to a few days and can include mental confusion, paranoid ideation, and audi-
tory hallucinations. In some cases, toxicity can mimic a functional psychosis such as paranoid 
schizophrenia.50 Severity of adverse psychological events is dependent upon the amount used, the 
pattern of use, other substances used, and the presence of any pre-existing psychiatric illnesses.51 
Withdrawal from methamphetamine use can induce symptoms of depression, need for 
seclusion, hyperphagia (abnormally increased appetite and consumption of food), and hypersom-
nia. Withdrawal syndromes are rarely life-threatening yet may require hospitalization, particularly 
in cases of severe depression.52 Pharmacotherapies such as benzodiazepines and antipsychotics 
are sometimes used to aid withdrawal or reduce the symptoms of psychosis.53 Despite ongoing 
research, substitution therapies for methamphetamine dependence remains unavailable.54
The Rise of a Compulsory Drug Treatment/Detention 
Center Model 
The rise in methamphetamine-related arrests in the Southeast Asian region has been paralleled by 
increased testing for amphetamine use, including compulsory testing, and an associated demand 
to treat those who test positive. In Thailand, a lack of infrastructure to treat methamphetamine 
users and limited treatment options have resulted in increasing numbers of young methamphet-
amine users being sent to prisons and CDTDCs.55 In 2004, there were 35 CDTDCs in Thailand; 
currently there are 84.56 A similar approach is gaining momentum in Cambodia (from zero to 14 
CDTDCs in eight years57) and in Laos (from zero to eight CDTDCs in ten years58). While some 
heroin and other drug users are also detained in these CDTDCs, they remain predominantly ﬁlled 
with methamphetamine users.59
The CDTDCs in Thailand, Cambodia, and Laos are predominantly managed by either the 
military or law enforcement sectors, and the drug treatment regimes implemented in these cen-
ters are based upon a military “boot camp” type model. Detainees are subjected to early morning 
wake-ups and physical exercises, and are often indoctrinated with anti-drug rhetoric. The system 
in Thailand is more regulated than that in Cambodia and Laos, with CDTDCs often located within 
military barracks. In many cases, detainees report inadequate food and shelter. Some CDTDCs 
in Thailand are managed by the Ministry of Interior, rather than the armed forces, and there are 
greater concerns as to the conditions in these centers. In Cambodia and Laos, CDTDCs are also 
run by military or public security personnel. Qualiﬁed health sector personnel are rarely involved 
in any aspects of drug treatment in the centers.
Figure 2. Proliferation of CDTDCs
International Concern about Compulsory Drug 
Treatment/Detention Centers
In recent years the international community, including human rights groups, UN agencies, legal 
and policy analysts, and drug treatment professionals have called for a review and restructuring of 
how the public security and public health systems in Southeast Asia implement drug treatment.60 
WHO and UNODC,61 for example, have stated clearly that drug treatment should be evidence-
based, promote prevention of HIV and other communicable disease transmission, and should not 
violate the human rights of detainees. Further, these agencies have outlined nine principles for 
guiding treatment of drug dependence. These recommendations include screening, assessment, 
diagnosis, and treatment planning; evidence-informed treatment; respect for human rights and 
dignity; and community involvement and patient participation.62 The CDTDCs in Southeast Asia 
violate all of these principles.
Manfred Nowak, the UN Special Rapporteur on Torture, has also made it clear that CDTDCs 
violate international standards on torture and cruel, inhuman, and degrading treatment.63 His 
2009 report to the Human Rights Council details examples of situations where abuses of drug 
users in the name of treatment, including detention in CDTDCs, violate the Convention Against 
Torture, as well as the protections inherent in the International Covenant on Civil and Political 
Rights against the use of non-consensual medical treatment and experimentation. Professor 
Nowak has further suggested that the lack of access to HIV prevention options for drug users in 
high-risk settings; ill treatment at the hands of police; lack of judicial review in the forced deten-
tions of drug users; and forced testing of HIV all raise signiﬁcant human rights concerns. 
Other leading ﬁgures, including Anand Grover, the UN Special Rapporteur on the Right to 
Health, and Navanethem Pillay, the UN High Commissioner for Human Rights, have expressed 
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similar concerns about human rights abuses committed in the name of drug treatment.64 
International NGOs have examined the practices of CDTDCs and documented multiple rights 
violations committed in the name of drug treatment.65 While the majority of these reports have 
focused on the forced treatment of injecting drug users, this report seeks to highlight that multiple 
human rights violations and negative individual and public health outcomes are also prevalent in 
the case of compulsory detention of primarily non-injecting methamphetamine users in Thailand, 
Cambodia, and Laos.
Health Implications of Compulsory Detention 
Even though methamphetamine is predominantly inhaled in Thailand, Cambodia, and Laos, once 
inside either a prison or a CDTDC, exposure to blood-borne viruses and other infectious disease 
increases. Incarceration or institutionalization of drug users in custodial settings has been asso-
ciated with a host of negative health outcomes including STIs and blood-borne viruses such as 
syphilis,66 herpes,67 HIV,68 hepatitis B,69 and hepatitis C.70 While these infections also exist outside 
of closed settings, it is clear that the custodial environment exposes individuals to behaviors and 
events that increase negative health outcomes. In Southeast Asia, prevalent behaviors or events 
include tattooing, injection of drugs,71 penile modiﬁcations,72 unprotected sex, and rape.73 Risk in 
CDTDCs is increased by the absence of HIV preventive measures. Of the three countries consid-
ered here, none makes condoms, sterile injection equipment, or tattooing paraphernalia available 
to detainees.
Thailand 
Drug Policy, Availability, and Use
Thailand formalized a ban on opium in 1959 when Prime Minister Sarit introduced the Harmful 
Habit Forming Drugs Act, which outlawed the production, sale, and use of opium.74 Several 
decades of alternative development in the highlands, largely supported and subsidized by the 
royal family of Thailand, has contributed to Thailand currently being recognized as essentially 
free of opium production.75
Thailand became a signatory to the 1961 United Nations Single Convention that year, and 
in 1975 signed onto  the 1971 UN Convention on Psychotropic Substances, and in 2002 ratiﬁed 
the UN Convention against Illicit Trafﬁcking in Narcotics.76 In 1976, the country introduced leg-
islation known as the Narcotic Control Act77 and established the Ofﬁce of the Narcotics Control 
Board (ONCB), with the Prime Minister as chair. The ONCB is the lead authority coordinating 
all anti-drugs efforts in Thailand. Under the terms of legal amendments and ONCB guidelines 
issued in 2002 and 2007, the possession and consumption of narcotics can result in ﬁnes and/
or incarceration sentences of up to 10 years. Methamphetamine was criminalized in 1996; those 
convicted of trafﬁcking in heroin and/or methamphetamine may be sentenced to death.78
In addition to national narcotics laws, Thailand is heavily engaged in regional and inter-
national drug enforcement. This includes, since 1993, cooperation in the UNODC regional 
Memorandum of Understanding on Drug Control and a commitment to the Association of 
Southeast Asian Nations (ASEAN) and China Cooperative Operations in Response to Dangerous 
Drugs (ACCORD) project.79 The US government has long supported antinarcotics efforts in 
Thailand through the provision of law enforcement trainings80 and the ONCB also has strong 
links to the US Drug Enforcement Agency.81 The website of the ONCB claims that Thailand is con-
sistently and actively involved in bilateral and multilateral law enforcement activities in Southeast 
Asia and gives full cooperation to foreign countries on matters of drugs control.82 
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Methamphetamine: Implications for Individual and 
Public Health 
Scientiﬁc research on issues of illicit drug use and public health in Thailand has traditionally 
focused on HIV risk behaviors and incidence rates among cohorts of injecting heroin users.83 As 
the number of heroin users tapered off in the late 1990s84 and the numbers of methamphetamine 
users increased, research efforts began to explore patterns of methamphetamine use and the 
implications of its effect on individual and public health. 
The ﬁrst Thai national household survey was conducted by the Academic Committee on 
Substance Abuse in 2001. It estimated that 3,500,000 million Thais between the ages of 15 and 60 
reported ever using methamphetamine. A second survey, in 2003, suggested that approximately 
1 million people in Thailand had used methamphetamine in the previous year. The survey also 
found that of the 450,000 people who reported using methamphetamine within the last 30 days, 
73 percent were between 12 and 24 years old.85
Research has shown differences between methamphetamine users and injecting opiate 
users. Between 1999 and 2000, researchers investigated the sociodemographic, sexual, and drug 
use risk factors among methamphetamine users accessing drug treatment in northern Thailand.86 
The study investigated data from 750 methamphetamine users and found that they had a higher 
number of sexual partners and higher rates of STIs when compared with heroin users. While 
HIV infection rates are higher among injecting drug users, another study conﬁrmed that meth-
amphetamine users are more likely to have HIV than the general Thai population.87 Among 1,890 
methamphetamine users who predominantly inhaled the drug, HIV prevalence in this population 
was 2.4 percent, almost double Thailand’s national HIV prevalence rate. 
Referral to Treatment
The Narcotic Addict Rehabilitation Act, which came into effect in 2002, states the government of 
Thailand’s legal response to treat and rehabilitate those addicted to narcotics. A comprehensive 
review of the Narcotic Addict Rehabilitation Act has recently been conducted by the Canadian HIV/
AIDS Legal Network and provides recommendations for improvements.88 
The Narcotic Addict Rehabilitation Act legislates that drug users are to be considered patients 
and have their cases reviewed by a Narcotic Rehabilitation Act Committee (NRAC), established 
in every province, which reviews each arrest for drug use (in the absence of other crimes) and 
makes a decision about what should happen to the alleged drug user. The committee is made up 
of psychologists, psychiatrists, community health workers, and key community leaders.89 The 
options open to the committee include: refer the person to compulsory four-month detention in a 
CDTDC; release the person back to the community to undertake supervised outpatient cognitive 
behavioral therapy; release the person back to the community with no further action; or recom-
mend prosecuting the person in the criminal court for a potential prison sentence. 
To help guide the committee, the Department of Probation, in conjunction with the arresting 
police ofﬁcer, puts together an investigation of the particular case in question. At no stage in the 
investigation does the NRAC actually meet with the alleged user,90 thereby limiting their ability to 
make an accurate medical assessment of the severity of dependence or the person’s mental health 
needs. Committee members acknowledge that this results in many methamphetamine users who 
are not drug dependent being sent to the CDTDCs.91 While investigation is ongoing, the individual 
is detained in a custodial setting, often a prison. While detention is not supposed to exceed 45 
days according to policy, in practice those imprisoned may remain for as long as a year. Medical 
assessments are not carried out during the investigation and therefore those people who may be 
methamphetamine dependent receive no medical assistance to ease symptoms of withdrawal.92
The Department of Probation states that any individual who has a case being investigated 
for an NRAC hearing is to be kept separate from prisoners.93 Those awaiting a hearing, however, 
are subject to the same poor prison conditions.94 Wanchai Roujanavong, then Director-General of 
the Department of Probation admitted: 
“In many cases prisons are used to detain methamphetamine users as there is no 
room anywhere else.”
95
Methamphetamine withdrawal is usually completed with no trial, due process, or medi-
cal supervision,96 and then detainees are frequently committed to involuntary detention for an 
additional three to four months. One methamphetamine user who had recently left a military-run 
CDTDC outside of Chiang Mai noted:
“I was arrested for two methamphetamine tablets and put in prison; I stayed there 
for 11 months and then one day was moved to a boot-camp. After three months in 
the boot-camp I was released.”
97
The Department of Probation supports the NRAC by providing 500 baht (US$15) to each 
committee member per meeting attended.98 In addition, the Department of Probation provides 
CDTDC management with 18,000 baht (US$540) for each person detained in a CDTDC. CDTDCs 
can hold between 30 and 400 people depending on their size, but the average CDTDC holds 100 
people. The Department of Probation estimated that more than 10,000 people passed through 
these CDTDCs in 2008 in Thailand.99 The Royal Thai Airforce, however, stated that the govern-
ment expected at least 50,000 people to pass through the system in 2009.100 The Department of 
Probation provides the money to CDTDC management upon receipt of quarterly reports submitted 
by CDTDC staff. Conversations with Department of Probation ofﬁcials suggest that the budget pro-
vided to some CDTDCs, particularly those under the auspices of Ministry of Interior, is frequently 
unaccounted for, resulting in low morale for unpaid staff and concern about theft.101
Discussions with various NRACs from across Thailand102 highlight the multiple issues fac-
ing the committees, including insufﬁcient time to review cases, and lag times of several months 
in payment for committee members. A senior psychiatrist from Rajburi Province, who serves on 
the NRAC notes:
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“We have up to 50 cases a week to hear, but we only meet for two hours once a 
week. It means we have only a couple of minutes to review each case and make a 
recommendation. It is not enough time but we have so much to do outside of the 
NRAC that it is the only time we can give. Our committee has not received its 
budget for the last four months.”
103
If the goal of the National Rehabilitation Act was to divert patients from the prison 
environment, this has clearly failed as a result of spikes in arrests of methamphetamine users, 
insufﬁcient budgets for the NRAC, and limited alternatives to incarceration. The end result is that 
methamphetamine users are still likely to spend a period of time either in prison or in a CDTDC. 
Thailand’s prison system has long been associated with overcrowding, high rates of HIV and 
tuberculosis infection, and inadequate staff-to-prisoner ratios.104 Detainees, who by law are meant 
to be considered “patients,” are therefore essentially treated like criminals and are thus sentenced 
both to time in prison and CDTDCs, and to negative health outcomes. 
Conditions Inside the Compulsory Drug Treatment/
Detention Centers
Recent downsizing of the Thai military has led to many of the provincial military barracks being 
converted into CDTDCs and run by the military on behalf of the Department of Probation.105 These 
CDTDCs are run like military boot-camps with an emphasis on exercise regimens, discipline, and 
time spent reciting anti-drug rhetoric. One recently released 23-year-old male from the camp in 
Chiang Dao noted:
“After waking up at 5 am we exercised until 7 am, ate breakfast, and then spent 
the rest of the morning listening to one of the army guys tell us about why drugs 
were bad.”
106
The “Jirasa Model” is the predominant program operating in the Air Force-run CDTDCs. 
The “Jirasa Model” is a combination of selected activities from a therapeutic community model and 
military principles including discipline, military drills, leadership training, and exercise. 
The daily routine consists of: a 5 am wake-up call; morning prayers and meditation; jogging; 
cleaning living quarters; breakfast; paying respect to the national ﬂag; muscle stretching; small 
group meeting with counselor; lunch; life skills; military drills and discipline; muscle strength 
training; sports; dinner; paying respect to the ﬂag; prayers and meditation; paying respect to the 
king; checking water taps and turning off lights for an 8:30 pm bedtime.107
Fifty of 84 CDTDCs are implemented by military personnel.108 Many of the CDTDCs report that 
visits by a qualiﬁed medical practitioner are intermittent and a nurse may visit one morning a week:
“We see the doctor about once every couple of weeks and the nurse sometimes 
one morning a month, and otherwise there is no health staff anywhere. The only 
medicines we have are paracetamol.”
109
This does not constitute medically supervised treatment as per the principles of drug depen-
dence treatment released by UNODC and WHO.110 The Thai Department of Mental Health is 
nominally in charge of the program design, but discussions with the department suggest they are 
actually not effectively involved at all. The Deputy Secretary General of the Department of Mental 
Health indicated that divisions between the Ministry of Public Health and the Department of 
Probation limited involvement of the Department of Mental Health in the management, evalua-
tion, and technical support of the CDTDCs.111 
Ten of the CDTDCs are run by the Ministry of Interior, rather than the military.112 The 
Department of Probation acknowledges that the conditions in the CDTDCs that are managed by 
the Ministry of Interior are much harsher than those in CDTDCs run by the military,113 with little 
accountability for budgets allocated for these CDTDCs. One senior ofﬁcial who worked in one of 
the CDTDCs managed by the Ministry of Interior said: 
“It’s very tough; we have no budgets, no assistance, and no idea what we are 
doing.”
114
 
A visit to a police-run CDTDC in Udon Thani, in northeast Thailand, conﬁrmed that condi-
tions were poor, with patients receiving no medical checks, and being subjected to harsh discipline 
such as chaining and beating. When asked why a Thai male was tethered by a heavy steel chain 
around his neck to a concrete pillar in the middle of the center, the same senior staff member 
responded:
 “He is being unsociable; we have asked the NRAC to remove him from here 
and send him to a hospital, as we think he has a mental illness, but they are not 
meeting this month; we will have to wait for another month.”
115
Research conducted by the Canadian HIV/AIDS Legal Network uncovered allegations of 
physical beatings used to discipline inmates for breaches of CDTDC rules, including engaging in 
consensual sexual activity. 
While reports have not detailed rapes in CDTDCs, such behaviors have been widely docu-
mented in Thai prisons. Despite this, the Department of Probation does not provide condoms 
either to those imprisoned and awaiting disposition by the NRAC, or in the CDTDCs. As of early 
2010, services for voluntary counseling and testing for HIV and the provision of anti-retroviral 
treatment were unavailable in the CDTDCs in Thailand.116
Release and Recidivism 
After three to four months in detention, detainees are released back to their communities with no 
pre-release health screening, no medical referrals, no job placement, and every chance of return-
ing to methamphetamine use. Despite the documented need for relapse prevention efforts upon 
release from drug treatment, no such programs are available and return to drug use is common. 
As one former detainee stated: 
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“It is just so nice to be free after prison and then the camp. You miss your friends 
because the camp is generally in another province away from your family and 
friends; when you see [your friends] again, you don’t worry about anything, and if 
they are smoking methamphetamine, so would I.”
117
Individuals are required to report to the provincial Department of Probation two months 
after release from the CDTDCs and submit to a compulsory urine test to screen for methamphet-
amines. This system is not monitored on a national scale, though interviews with ofﬁcials sug-
gest that some 20 percent of individuals test positive for methamphetamine within two months 
of release in parts of the country.118 In one large cohort study in northern Thailand, 70 percent 
of those arrested for methamphetamine use were arrested and incarcerated a second time after 
release.119
Proliferation of the Compulsory Drug Treatment/
Detention Centers
In Thailand, in the year 2000, there were six CDTDCs; in 2004 there were 35 CDTDCs; by 2005 
this number had increased to 49;120 and at the close of 2008, there were 84 CDTDCs operating 
in military barracks in Thailand.121 Wanchai Roujanavong, the previous Director-General of the 
Department of Probation stated that continued expansion of the CDTDC model was the goal, and 
that they would like to see another 25 CDTDCs set up (this would mean at least one CDTDC in 
every province of the country), as he believed that only 25 percent of people who should be sent 
to CDTDCs were currently being admitted.122 
The prime minister of Thailand stated in March 2009 that the aim of Thailand’s next phase 
of a “war on drugs” was to get 120,000 people into rehabilitation programs.123 If this was to be 
done utilizing the CDTDCs, Thailand would need to build another 300 facilities. In February 
2010, that call was renewed with a plan by the Deputy Prime Minister to send 300,000 drug 
addicts for treatment—half of those to CDTDCs—by the close of the ﬁscal year.124 There has been 
no large-scale evaluation done in Thailand as to the effectiveness of the CDTDCs in preventing 
relapse to drug use.
Figure 3. Detained methamphetamine users undergo military-style training at a CDTDC 
in Thailand in April 2009
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Cambodia
Drug Policy, Availability, and Use
Cambodia, unlike neighboring Thailand, Laos, and Vietnam, had no tradition of opium cultiva-
tion125 and was never considered part of the area of illicit opiate production known as the “Golden 
Triangle.” The UN peacekeeping operation and the 1993 election led to foreign investment, 
increased trade, and the use of Cambodia as a transit point for heroin and cannabis, which were 
smuggled out of the country’s two ports: Sihanoukville and Koh Kong. In 2001, the International 
Labour Organization cited a 1995 report from the The Cambodia Daily: 
“Smugglers of illegal narcotics are increasingly using Cambodia as a transit point 
for the drugs which are heading primarily to United States and European markets 
… Ministry of Interior ofﬁcials have pointed to Banteay Meanchey Province, on 
the northwestern Thai border and the coastal Koh Kong Province as the current 
narcotic smuggling “hot spots” … hundreds of kilograms of heroin are seized by 
anti-narcotic ofﬁcials every month.”
126
By 1996, Cambodia had been added to the US State Department’s list of countries that 
needed to take greater action to control production or trafﬁcking of illicit drugs.127 This was a clas-
siﬁcation the Cambodian government contested, noting that they were in fact a transit country 
in need of greater international law enforcement support.128 While formal assessments were not 
published, anecdotal reports documented increased production, trafﬁcking, and use of metham-
phetamine tablets in Cambodia from the beginning of 2000. A report in the Far East Economic 
Review in 2001, cited by the International Labour Organization, notes: 
“Thousands of poor farmers on the northwestern border with Thailand daily pop 
two to three pills of yama (which means horse medicine in Thai) to work longer 
and stave off hunger… Dealers are using Cambodia as a dumping ground for pills 
made in Burma that sell for just under US$1 each to an alarming number of rural 
labourers... Sopheap is one of thousands of Khmer Rouge ﬁghters who defected to 
the army before being disbanded … He began taking yama when working for a 
3 1
3 2   C A M B O D I A
Thai logging company in Cambodia for a meager but steady income. The more 
wood he cut, the more money he got. So he was happy to try a pill that promised 
to increase his productivity.”
129
By 2002, the large-scale presence of methamphetamine was ofﬁcially conﬁrmed with an 
estimated 81 percent increase from 2001 in the seizure of methamphetamine tablets.130 One US 
State Department report said that:
“Cambodia has experienced a signiﬁcant increase in the amount of amphetamine-
type stimulants transiting from the Golden Triangle. The UNODC estimates that 
100,000 methamphetamine tablets entered Cambodia each day, some 75 percent 
of which are thought to be exported to Thailand.”
131
 
A UNODC report from 2002 noted that yama tablets132 were so readily available in the 
border town of Poipet that the price of a single tablet decreased by nearly half, to 60 cents, in 
the past two years.133 While much yama trafﬁcking in border areas was attributed to the import 
of drugs manufactured in Burma, drug control authorities subsequently conﬁrmed methamphet-
amine production within Cambodia and noted discoveries of laboratories capable of producing 
precursor chemicals and crystal methamphetamine powder, and seizures of precursor chemicals 
and tablet-pressing machinery.134
Methamphetamine has been ranked the most commonly abused drug in Cambodia since 
2003, with abuse increasing every year between 2003 and 2006.135 In 2007, the National Authority 
for Combating Drugs (NACD) stated that methamphetamine accounted for 80 percent of all illicit 
drug use and that more than 80 percent of users were under 25 years old.136 
In addition to methamphetamine tablets, crystal methamphetamine (known as ice), has 
become increasingly available in Cambodia. In 2007, one study showed that 42 percent of street 
children sampled had used crystal methamphetamine.137 Estimates of the total number of drug 
users in Cambodia remain unclear and differ greatly; the NACD estimated that there were 5,797 
drug users in 2007 and UNAIDS estimated that there were 46,300 problematic illicit drug users 
for the same period.138
Methamphetamine: Implications for Individual and 
Public Health 
In 2007, the National Centre for HIV, Dermatology and STIs (NCHADS) conducted a study of 
methamphetamine use among women in the entertainment industry in Cambodia and suggested 
that methamphetamine use was associated with a higher number of sex partners. The study also 
suggested associations between methamphetamine use and HIV infection among sex workers in 
Cambodia.139 The NACD also reported HIV associated with drug use (including opiate injection) 
in a small sample (n=77) of injecting drug users who showed an HIV prevalence of 35 percent and 
another survey of 647 non-injecting drug users who showed HIV prevalence of 3.7 percent.140 Both 
ﬁgures are well above the 2007 national HIV prevalence estimated by sentinel surveillance at 0.9 
percent141 and prompted recognition of the need for a harm reduction approach to both injecting 
and non-injecting drug use. This has led to an authorization that currently allows one NGO to 
provide clean needles and syringes through outreach programs in the capital, Phnom Penh. At the 
time of this report, Cambodia was preparing to begin its ﬁrst methadone maintenance program.142 
Methamphetamine is primarily smoked143 and harm reduction responses to non-injecting drug 
use in Cambodia remain scant.
Stimulant users in Cambodia report several other behaviors that increase risk of disease 
or arrest. A 2008 cross-sectional study conducted among methamphetamine users in and out 
of CDTDCs explored STI prevalence, rates of arrest, and other individual and public health con-
cerns.144 The study population (n=651) was overwhelmingly male (96 percent); only 30 percent had 
completed high school; 46 percent of those surveyed used methamphetamine four or more times a 
week; and after using methamphetamine they drank alcohol (68 percent), had sex (60 percent), or 
engaged in ﬁghting (33 percent). Half reported that methamphetamine use increased their sexual 
desire, and 60 percent reported having sex while high on methamphetamine or alcohol or both. 
Female users in the sample were almost nine times more likely than non-users to test positive for 
chlamydia (27 percent vs. 3.9 percent).
Nearly two-thirds of these methamphetamine users (61 percent) had passed through the 
CDTDCs previously and the median duration of stay in such a center was 90 days. Two-thirds of 
those surveyed (65 percent) were forced to enroll by their families, and 30 percent were forced 
into the CDTDCs by the authorities.145
Figure 4. Compulsory Drug Treatment/Detention Centers in Cambodia (2009)
Fourteen CDTDCs operated in Cambodia in 2009. There were none in operation in 2000.146
Source: http://www.canbypublications.com/maps/simpleprov.htm.
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Referral to Treatment
Due process in cases of detention is a fundamental human right
 
applicable “to all deprivations 
of liberty, including non-criminal detention for drug dependency.”147 Despite this, procedures 
in Cambodia mandating treatment lack the most basic protections against arbitrariness. As one 
detainee notes: 
“I got arrested when I was walking with a group of friends. I was told the reason 
I was arrested was that I was walking with too many people at the same time 
(12 people). I didn’t go to court or face a trial. I was told I was a yama user and 
therefore required treatment.”
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Police roundups of drug users and others in Cambodia, including sex workers, are well docu-
mented,149 whether as part of “clean streets” campaigns prior to national holidays or elections, or 
in response to international or national dynamics. NGOs reported increased arrests of drug users 
and sex workers in 2008, for example, following the decision of the US government to downgrade 
Cambodia’s status related to efforts to combat human trafﬁcking.150
Instances of non-drug users being put in the CDTDCs have also been documented by human 
rights NGOs. A representative of a human rights organization commented on police roundups 
in Cambodia: 
“None of these people have been charged with any crime. They are arrested because 
they’re poor and because they’re either living or working on the streets. So they may 
be sex workers who are working on the streets, they may be street children, they may 
be street families who have no houses, they may be drug users; some of the people 
we met said they didn’t live or work on the streets, but because of the way they were 
dressed they were mistaken for poor people therefore they had to be homeless, so they 
were arrested and detained as well. So it’s very indiscriminate.”
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The 1997 Law on the Control of Drugs in Cambodia, amended in 2005 states that peo-
ple arrested and found to be dependent on illicit drugs, must appear before the court where an 
order may be made for them to enter CDTDCs. The expenses related to this treatment must be 
paid for by the state.152 Nonetheless, multiple case reports make clear that there was no medical 
assessment for severity of drug dependence, no judicial process, and no rights protections afforded 
to detainees prior to or during their internment in CDTDCs. Of six CDTDCs visited by WHO 
in collaboration with a government team in 2007, only one reported any form of pre-admission 
assessment (which was only a basic physical examination).153
In addition to police roundups, many methamphetamine users are sent to the CDTDCs by 
their parents, who are asked to sign a contract with the center. The law requires the entire costs 
of “treatment” to be provided by the government, although it is not known how much money (if 
any at all) is actually provided to the centers to cover the costs of detention.154 Despite government 
assurances that costs are covered by the state, families of drug users report that admission costs 
between US$100 and US$200, and relatives of detainees are expected to contribute US$50 per 
month.155 The average salary in Cambodia in 2008 was US$167 per month.156 
Conditions Inside the Compulsory Drug Treatment/
Detention Centers
Currently, CDTDCs share no common standards, though all report deﬁciencies in human 
resources, and no mechanism exists to ensure observance of minimum standards. As an assistant 
to the Secretary General of NACD notes:
“Each drug treatment center has its own regulations and all of them lack human 
resources. Several regimens are based on military drills and exercise, with little or 
no treatment and scant vocational resources.”
157
The ﬁndings from a WHO report conducted in 2007 are consistent with the ﬁndings from 
this assessment. Both reports indicate that most of the CDTDCs in Cambodia do not have health 
professionals on staff, which severely limits their ability to provide medical assistance in the case 
of emergencies, or even assist with treatment of withdrawal associated with drug dependence or 
to provide psychological counseling.158 The similarities in the ﬁndings from the WHO report and 
this assessment indicate that recommendations made to address the concerns raised in the WHO 
report have not been implemented. In this assessment, many former detainees report that they 
did not receive any health check upon admission to the CDTDCs, received no health care while 
they were in the CDTDCs, and relapsed back to methamphetamine use immediately upon release. 
WHO staff in Cambodia estimate that the lack of any qualiﬁed staff or evidence-based treatment 
has probably led to a relapse rate of almost 100 percent.159 As one former detainee interviewed for 
this report recalled:
“I didn’t receive any health checks or health care. There was no medication. Drug 
treatment consisted of a daily boot-camp regimen. Wake up, exercise, shower, 
salute the ﬂag, have boot-camp, go into work groups, lock up, eat, lock up, sleep. 
There was no education about drugs, they just told us to stay clean. They said that 
if we wanted to stay off drugs we had to ﬁnd a job.”
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Many detainees have reported beatings in the CDTDCs. Two men said:
“All the staff carried around a bamboo stick, and if they saw people that weren’t 
working they would hit them across the back.”
161
“I saw three staff beat a guy unconscious; they then dragged him away to another 
room. They also beat me once, but they put a blanket over my head so I couldn’t 
see or defend myself.”
162
 
Others mentioned the forced labor that they were assigned, including menial tasks that 
could not qualify as vocational training or drug treatment. These tasks were uncompensated and 
often seemed pointless or degrading.
“We had to cut the grass for one hour a day with a pair of scissors.”
163
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“We had to dig holes in the dirt. But we were not digging for any reason, 
they just didn’t know what to do with us so they made us dig holes and then ﬁll 
them in.”
164
Figure 5. Sleeping quarters in the Bavel CDTDC, Cambodia (May 2008)
Source: Patrick Duigan.
People released describe overcrowding, poor hygienic practices, the detention of people 
under 18 years old alongside adults, as well as the detention of people with mental illness: 
“There were about 70 of us put in one room of about 20 by 30 feet. It felt very 
crowded, and it was ﬁlthy. There was a mix of people in there: drug users, homeless, 
alcoholics. The youngest person was six, and the oldest about 37.”
165
The Convention on the Rights of the Child states that detaining adults and juveniles together 
violates international norms, noting that juveniles should be detained with adults only as a “last 
resort.”166 In their fourth quarterly report in 2007, the NACD’s routine analysis of data provided 
by government-run CDTDCs showed that 31 percent of the 357 treatment admissions were of 
people younger than 18 years old.167 In the CDTDCs in Cambodia, there is no reported effort to 
separate adult and juvenile detainees, which is in clear violation of the Convention of the Rights 
of the Child.
Patrick Duigan, MD, based with the International Ofﬁce on Migration in Phnom Penh, 
visited several CDTDCs in 2008 in an effort to understand the extent of health concerns in the 
CDTDCs. He visited the center in Sisophon, the capital of Banteay Meanchey Province, which 
opened in 2002 and is run by military police, and noted that many detainees appeared to be suf-
fering a range of health concerns attributed to malnutrition. He also suggested that mental health 
problems were rife and many detainees made regular attempts to escape.168 In the Bavel Detention 
Center, in Battambang Province, also run by the military police, he noted that the majority of 
detainees were extremely poor and that there was “absolutely no rehabilitation activity and no 
skills training.”169
Figure 6. Bavel District CDTDC, Cambodia (May 2008)
Source: Patrick Duigan.
International literature widely documents that HIV risk in closed settings is increased due 
to consensual and non-consensual sex and the sharing of needles for either drug use or tattoo-
ing.170 Despite this, condoms are not available in CDTDCs in Cambodia and neither are sterile 
implements for the purposes of tattooing. Furthermore, none of the CDTDCs visited during the 
WHO assessment provided STI testing or treatment, despite the known STI risk proﬁles of meth-
amphetamine users in Cambodia.171 As one recently released female noted:
“There was tattooing and piercing going on, and there were men who had sex with 
the lady boys.”
172
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Another reported:
“There was lots of HIV risk behavior. There was a lot of penile piercing and a lot of 
sex and rape between inmates and staff and inmates and inmates. Sometimes the 
staff would pay the prettier girls for sex but usually only 5000 Riel (US$1.20).”
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In addition, there were reports of detainees being asked to perform sex work by guards who 
took a share of the proceeds. As a recently released female noted: 
“The guards pimp the inmates—the ones that are sex workers—as well. They let 
them go out all night and get as high as they like, as long as the girls give them 
all the money they made in the morning. These girls are also the ones that bring 
yama tablets back into the center.”
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Penile modiﬁcation has been documented in half of the male methamphetamine users in 
a recent study in northern Thailand175 and the majority of those who had modiﬁed had done so 
while in some form of custodial setting. While studies have not detailed the extent of the practice 
in Cambodian prisons or CDTDCs, multiple interviews noted the prevalence of both penile modi-
ﬁcation and tattooing in the CDTDCs: 
“Yes, I have seen it a lot. People sharpen a toothbrush and make a slit in the shaft 
of the penis in which to push marbles.”
176
“There was tattooing, they used needles and mixed charcoal and toothpaste 
together to make ink. There were also people having sex.”
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Overcrowding and conﬁnement in close proximity to others elevates the risk of tuberculosis 
transmission and infection,178 yet none of the CDTDCs in Cambodia provide tuberculosis screen-
ing or treatment.
Although HIV rates are unknown, reported sexual and drug use histories of metham-
phetamine users suggest many people detained are at risk of or infected with HIV. None of the 
CDTDCs currently offers voluntary HIV counseling and testing or antiretroviral treatment, nor 
referral to such services even when they are available near the center.179 
Release and Recidivism 
Not only is admission to detention in the CDTDCs in Cambodia arbitrary, but so too are the cir-
cumstances of release. The assistant to the Secretary General of NACD explained: 
“It is not very clear how patients are released but most likely doctors will decide if 
someone can go or not. Some people could stay four or ﬁve years.”
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A recent study showed that most people are released after a median detention time of three 
months.181 The release criteria are unclear but informal discussions with staff suggest one of the 
criteria for release includes a detainee’s demonstrated ability to recite the Cambodian National 
Drug Laws from memory. Recitation of the laws forms part of the daily routine of detainees in the 
CDTDCs in Cambodia.182
No formal evaluations have yet been conducted to assess the effectiveness of the CDTDCs in 
preventing relapse to methamphetamine use upon release, although experts working in Cambodia 
estimate that the relapse rate is close to 100 percent.183 WHO reports that they plan to assist the 
government of Cambodia to undertake evaluation in the near future.184 
Proliferation of the Compulsory Drug Treatment/
Detention Centers
In an interview with The Cambodia Daily in 2004, the Cambodian government announced plans 
to build its ﬁrst drug rehabilitation center, with 300 beds, in Phnom Penh. On October 23, 2006, 
the Prime Minister of Cambodia, Hun Sen, released The Implementation of Education, Treatment 
and Rehabilitation Measures for Drug Addicts. The instruction called upon all concerned ministries, 
agencies, and provincial and municipal authorities to implement several strategies without delay, 
including ﬁnding one location in each province to organize a “drug addict treatment and rehabili-
tation center.”185 The instruction recommended that the Ministry of Health “create a drug addict 
treatment unit at the national level in Phnom Penh, arrange consultation services at provincial-
municipal and district referral hospitals to advise and cure drug addicts sent to the hospitals by 
their parents, develop technical standards to control drug addict treatment services in communi-
ties’ drug treatment and rehabilitation centers, and eliminate treatment places that are not autho-
rized by the Ministry of Health.” The Prime Minister also called on communities, families, and 
former drug addicts to create model drug-free communities.186
There are currently 14 CDTDCs nationwide, run by government ministries, plus at least 
four NGO-run centers.187 In a recent interview, Prum Sokha, Secretary of State at the Ministry of 
Interior, called the CDTDCs:
 “…ad hoc accidental creations, which do not really offer treatment. What we need 
is not a technical solution but a comprehensive one bringing together education, 
drug users’ families, and the community—this is very important.”
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None of the 14 state-managed CDTDCs are currently operated by the Ministry of Health. 
Instead, the CDTDCs are predominately operated by the Military Police of the Royal Cambodian 
Armed Forces, which is a component of the Ministry of National Defense. Some CDTDCs are run 
by police (overseen by the Ministry of Interior), and a small number of CDTDCs are run by the 
Ministry of Social Affairs, Veterans and Youth Rehabilitation.189 According to staff at the Ministry of 
Health, H.E. Dr. Mam Bun Heng, Secretary of State for the Ministry of Health, is reported to have 
stated in mid-2008 that all such CDTDCs operate outside of the ofﬁcial mandate of the Ministry 
of Health and that his ministry had no jurisdiction to intervene in such premises.190
In 2010, the Deputy Prime Minister announced a plan to reduce the number of centers to 
one by 2015. However, the proposed center would hold as many people as the other centers com-
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bined. In addition, this center would be run by the NACD rather than the Ministry of Health.191 
As this report went to print, the UN Country Team in Cambodia issued a statement welcoming 
the government plan to scale down to one center; the statement, however, stops short of calling 
for the closure of all CDTDCs in Cambodia (see Annex 3). In fact, the UN Country Team agrees 
to provide assistance to the centers, provided certain conditions are met, an agreement that risks 
sounding like an endorsement of the CDTDC model. Subsequent to the UN Country Team state-
ment, Michel Sidibé, the director of UNAIDS, issued a directive clearly calling for the closure of all 
Cambodia’s CDTDCs, saying “I am asking relevant partners to join me in intensifying UN system 
support toward: the earliest possible closure of detention centres, which do not meet minimum 
standards in Cambodia and other countries. 192
Laos
Drug Policy, Availability, and Use
Drug production and use in Laos has traditionally centered on the cultivation of opium; in fact, 
since the 1950s, Laos has been one of the world’s major opium producers.193 Much of the opium 
has been consumed in a traditional cultural context.194 It has been used for both medicinal and 
social purposes and indeed is also grown as a cash crop. Opium was so central to the fundamental 
economy and culture of many of the ethnic groups living in the highlands of Laos that it struck 
many Laotians as strange that it would ever be considered illegal. Soubanh Srithirath, who was 
both the deputy foreign minister and the chairman of the Lao Commission for Drug Control and 
Supervision (LCDC), made a speech in November 1995 in which he urged westerners to be more 
understanding of opium as part of the “Lao Soung” way of life. Apparently aiming his remarks at 
some westerners who thought Laos was not doing enough to eradicate opium cultivation, Srithirath 
explained that for many people in the highlands “smoking opium is no different from the way you 
in the West drink wine.”195
Between 1975 and 1990, Laos was sustained by Soviet aid. Despite the presence of a US 
Embassy in Vientiane, the US Drug Enforcement Agency was unable to implement its war on 
drugs strategy throughout the period of the Cold War.196 However, as communism began to col-
lapse, western aid moved in to ﬁll the gap left by the Soviet Union. It was at this juncture that the 
US Government—in particular, the US Drug Enforcement Agency through its main international 
ally, the United Nations Drug Control Program (now the United Nations Ofﬁce on Drugs and 
Crime197)—stepped up pressure on the government of Laos to eradicate opium. In May 1999, 
an agreement was made between the president of Laos and the UN to eliminate opium produc-
tion in the region within six years through alternative development, demand reduction, and law 
enforcement.198 
In 2000, the UNDCP promised US$80 million to expedite opium elimination, and in 
December 2000, the prime minister issued Decree 14 mandating the total elimination of opium by 
2006.199 
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In 1989, opium cultivation peaked at an estimated 380 tons, and by 2007, Laos had only an 
estimated 9 tons of cultivated opium. This was heralded as a success by the UN, though observers 
noted that eradication efforts had consequences, including social dislocation, economic hardship, 
increased poverty,200 and large numbers of untreated opium-dependent people. Some observers 
also believe opium eradication contributed to the large-scale uptake of methamphetamine.201
At the beginning of the new millennium, at the same time as UNODC and western embas-
sies in Laos were pressuring the government to crack down on opium cultivation, methamphet-
amine tablets started to make their way across the Mekong River from Thailand and circulate 
among unemployed youth, sex workers, and nightclub goers in Vientiane.202 The ﬁrst docu-
mented seizure of methamphetamine tablets was reported in 1997, and by 1999 the Vientiane 
prefecture reported that 2.5 percent of youth between the ages of 13 and 30 in the capital Vientiane 
used yaba. Similar ﬁgures were reported from Savanakhet (3.5 percent) and Oudomxay (2.8 
percent).203 Thailand’s well documented “war on drugs” in 2003 was also believed to have con-
tributed to a change in the trafﬁcking routes of methamphetamine tablets. UNODC noted in 
2006 that methamphetamine tablet trafﬁcking moved to less policed and more vulnerable states 
such as Laos.204 
The alarming spread of methamphetamine tablets by 2003 caught authorities unaware, and 
caused some diplomats to question whether too much attention had been placed on opium. The 
Australian Ambassador at the time expressed serious misgivings, stating: 
“The international community has put too much focus on getting rid of opium, but 
this yaba problem is much worse, and we should be focused on that instead.”
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The Laos authorities became increasingly concerned about the widespread use of metham-
phetamine when it became apparent that the smuggling of methamphetamine tablets from Nong 
Khai, Thailand across the Mekong into Vientiane was affecting youth, including scions of the 
inﬂuential communist party and government ofﬁcials.206 Despite the emergence of methamphet-
amine, the donor community continued to devote resources to opium eradication, although only 
about 10% of the US $80 million pledged to the Laos government was ever received.207 Opium, 
which can be readily converted into heroin, was long a concern of the US and western countries, 
whereas methamphetamine tablets remained a domestic drug threat. 
Methamphetamine: Implications for Individual and
Public Health
Despite methamphetamine tablets being the most widely used illicit drug in Laos, there is a 
dearth of information on their implications for individual and public health. In 1999, UNODC, 
in conjunction with the Laos government, conducted a survey among students from 13 schools 
in Vientiane. It found that 4.8 percent of students between 12 and 21 years old (n=2631) in the 
survey reported using yaba and 11 percent of those had injected it.208 In the second round national 
HIV surveillance conducted in 2004, 15 percent of sex workers in Luang Namtha reported ever 
using amphetamines and 11 percent of those had injected in the last 12 months,209 although it is 
not clear what they injected. 
By 2005, the Asia and Paciﬁc Amphetamine-Type Stimulants Information Center (APAIC) 
reported that methamphetamine was the most widely used illicit drug in Laos, that 4.6 million 
tablets were seized that year, and that national drug arrest and seizure data showed that 90 per-
cent of drug-related arrests were related to methamphetamine. Males accounted for 72 percent 
of those arrested.210
A 2005 UNODC report stated that methamphetamine was increasingly available and used 
by different segments of society including laborers, school students, married men, and farm work-
ers.211 Participants in the survey commented that methamphetamine was being marketed as a drug 
that could help alleviate symptoms of opiate withdrawal. The report found that public perception 
and understanding of the health and societal impacts of methamphetamine use were low. Many 
people who used methamphetamine reported doing so to increase energy or make them stronger, 
and because they thought the drug could be used as a painkiller or opiate substitute. Participants 
interviewed for the report did note that methamphetamine use was associated with increased 
alcohol and tobacco use and increased sexual risk behavior. Individual and public health interven-
tions were deemed non-existent. Participants noted that those who used methamphetamine were 
also likely to be arrested, incarcerated for a period of time in police cells without any form of psy-
chological or medical treatment, and that they return to using methamphetamine upon release.212 
In 2006, the LCDC estimated that there were 5,000 methamphetamine users in Vientiane 
and 5,780 methamphetamine users in surrounding Vientiane Province.213 A study conducted 
between 2006 and 2007 with funding from AusAID’s Illicit Drugs Initiative aimed to explore 
the individual and public health implications of methamphetamine use among young people in 
Vientiane and Vientiane Province, including its implications for STIs, sexual risk behavior, and 
rates of arrest and incarceration. The 443 methamphetamine users interviewed were between 
the ages of 15 and 25, were predominantly male (90 percent), and used yaba at least once a week 
(46 percent). More than a third (38 percent) reported that methamphetamine increased sexual 
desire, and 54 percent of people reported drinking alcohol after taking methamphetamine. A high 
proportion of males reported having been drunk or high on methamphetamine while having sex. 
In addition, a high percentage of males reported frequenting female sex workers while either using 
methamphetamine (55 percent) or while drunk on alcohol (97 percent). Overall, 13.6 percent of 
participants screened positive for chlamydia; 32 percent of all females tested positive compared 
to 12 percent of males.214, 215
In 2008, the UNODC Laos country ofﬁce estimated that there were 35,000 to 40,000 
amphetamine-type stimulant addicts in the country.216 It is not clear how they arrived at this esti-
mate or how the notion of drug dependence and measurements of addiction were applied. A rapid 
escalation in the construction and use of CDTDCs, built with funds from international donors, 
has accompanied reports of increasing methamphetamine use.
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Referral to Treatment
Health personnel with limited training217 and communities and families of yaba users often turn 
to law enforcement for assistance in managing problematic methamphetamine users: 
“Sometimes the family could not treat their children anymore so they ask the police 
to send their children to the rehabilitation center. Thus the methamphetamine user 
will be arrested and kept at the village ofﬁce until working hours, when the head [of 
the] village, police, and parents come together and identify who are the yaba users 
and who are the dealers. The users will be sent to a rehabilitation center, and the 
dealers will have their case formally investigated by the police.”
218
In Laos, issues arising in a community are often dealt with by village mediation units. The 
village mediation units are a traditional platform for mediating adult disputes at a community level, 
and therefore obviate the need for involvement of state-based public security.219 Methamphetamine 
users are often accused of disturbing the peace and therefore ﬁnd themselves before village media-
tion units where they will typically be warned and asked to stop using methamphetamine. After 
several transgressions of community-set conditions, they may ﬁnd themselves being taken to a 
CDTDC by their own family, members of the community, or local police. As shown in Cambodia, 
activities after using methamphetamine include drinking and ﬁghting. These activities often result 
in arrest and incarceration in a CDTDC or a prison, particularly for those unable to pay ﬁnes: 
“Some of my friends used to ﬁght after using yaba, and the police arrested 
them and called the parents to mediate, and the parents paid a ﬁne of 500,000 
kip (50 USD).”
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Methamphetamine users also report that police use them as spies and informants:
“After being arrested, I was put in jail and they asked me where I had got the 
yaba. They asked me if I wanted to be a spy and communicate with the dealers. 
The police left me in prison for a week then gave me 500,000 kip (50 USD) and 
10 yaba tablets. If they didn’t keep me in prison for 10 days, the dealers would be 
suspicious and beat me.”
221
In many cases, methamphetamine users are rounded up by the police and incarcerated in 
a CDTDC without any legal review of the person’s status of drug dependence or of the perceived 
danger to the community that the detained person poses.222 Detention is also effected through a 
contract signed between parents of the detainee and the administrators of the CDTDCs, despite the 
fact that such documents have no legal validity for adults. The contract stipulates that treatment at 
the CDTDC will be for a period of at least six months and if the detainee runs away, the parents 
have the responsibility to return the person. 
Dr. Chantravady, one of only a few psychiatrists in Laos, laments the lack of preadmission 
health screening, particularly as it relates to diagnosis of mental health conditions, in a CDTDC 
on the outskirts of Vientiane, stating:
“I keep telling the directors of Somsagna Drug Rehabilitation Center the importance 
of screening and testing, but they still don’t do it. Without good screening and 
testing of new admissions, inmates who are suffering from mental health problems 
may be wrongly treated for drug problems.”
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Detention of Juveniles
The extent of compulsory detention of juveniles in Laos was initially uncovered by a government 
investigation conducted in conjunction with UNICEF in 2003.224 The UNICEF-sponsored investi-
gation visited 11 centers, both CDTDC and prisons,225 in seven provinces and found that as many 
as 150 detainees (the total numbers of people in all 11 centers was not given) were less than 18 
years old. The overwhelming majority of juveniles (88 percent) in the CDTDCs were incarcerated 
due to narcotics-related offenses, but the CDTDCs were also used to detain other juveniles accused 
of petty crimes.226 Many youth were unsure about the charges on which they were detained. 
The report detailed shortcomings of the detention system, including multiple violations of the 
Convention on the Rights of the Child. Few of the detainees had been formally sentenced. Eight 
percent of juveniles in the survey were under 15 and had been taken to the CDTDCs by their 
families or guardians. Less than 2 percent of crimes were considered of a serious enough nature 
under Lao law for detention, and conditions in the places of detention visited failed to meet basic 
requirements of international regulations, which include the provision of educational services, 
appropriate nutrition, and adequate health care. Nearly all juveniles were being detained with 
adults despite reporting abuses227 and a desire to be detained separately.228 Not one of the “treat-
ment” facilities in which they were detained had provided comprehensive drug rehabilitation 
services, nor did the CDTDCs employ any staff who had been trained in counseling techniques or 
treatment of drug-dependent children.229
While the government of Laos has been reluctant to allow outside groups to monitor condi-
tions inside the CDTDCs, in 2006, UNICEF did begin to monitor the numbers of children in deten-
tion. The Laos government stopped this activity shortly after it had begun. At that time, UNICEF 
had counted more than 600 child detainees in various detention facilities across the country.230
Conditions Inside the Compulsory Drug Treatment/
Detention Centers
Today there are eight CDTDCs at various stages of operation in Laos. The Somsagna Drug 
Rehabilitation Center was the ﬁrst; it was opened just outside of Vientiane in 1999 for 214 patients, 
under the control of the police. It had no facilities for any form of drug rehabilitation or treatment. 
In 2002, the management of Somsagna Drug Rehabilitation Center was taken out of the hands 
of police and put under the control of a board of directors under the supervision of the mayor of 
Vientiane.231 
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But even after the change in control, there were still problems with the center. It was one 
of the CDTDCs criticized in the 2003 UNICEF report. Several other investigations also high-
lighted the unacceptable conditions prevailing in Somsagna and conﬁrmed the ﬁndings of the 
initial investigation. A 2004 WHO report noted that the admission and discharge criteria were 
unclear, funds for food inadequate, and medical withdrawal from methamphetamine with phar-
macotherapy available but sporadic in its administration. In addition, detainees experienced high 
rates of common skin infections, beriberi (thiamine deﬁciency), and STIs. About 30 percent of 
those detained were under the age of 18, but were detained with adults.232 
By 2004, 2,658 detainees were in the Somsagna Drug Rehabilitation Center—more than ten 
times the number of detainees in 1999. By 2007, in the wake of repeated reports233 of abuses and 
appalling conditions, the number had decreased to 1,222.234 There are no facilities with which to 
diagnose or treat HIV, tuberculosis, or STIs, though in 2003, the Somsagna Drug Rehabilitation 
Center referred 120 detainees to the STI clinic within the Vientiane Youth Center.235 Despite a 
UNODC recommendation to conduct comprehensive health assessments upon admission into 
the CDTDCs,236 the lack of facilities, diagnostic instruments, and trained staff continues to limit 
the implementation of pre-admission health screening. In addition, reports from recently released 
detainees suggest that conditions have not improved:
“Each morning we got two scoops of rice soup and at lunch a handful of sticky 
rice and a bowl of soup that’s made from pork bones with very little meat. Maybe 
some soup, a handful of rice, and some vegetables for dinner. There is not enough 
water for drinking, showering, and washing. The toilets are ﬁlthy, and there are 
bags with shit lying around. We all eat and sleep in the same room, so that’s dirty 
too. Each room is about seven by ﬁve meters, and there are about 35 to 40 people 
in each room.”
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Rules outlining procedures and regulations for those in the Somsagna Drug Rehabilitation 
Center were drawn up by the director, Sisouphan Boupha, and speciﬁed the need for detainees to 
be reeducated in the drug laws of Laos and to receive party indoctrination.238 Other rules, which 
are still in effect today, include prohibitions against sexual activity, tattooing, or piercing.239 These 
prohibitions are not effective, as one staff member notes: 
“When you have many males locked up in a small space at night it is difﬁcult to 
know what goes on, but I have seen evidence that some of them do have sex, do 
participate in tattooing and penile modiﬁcations.”
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Despite the fact that sexual activity is forbidden, interviews with people who have recently 
been released from the Somsagna Drug Rehabilitation Center highlight that sexual activity, both 
consensual and nonconsensual, is highly prevalent and that condoms remain unavailable: 
“Yes, I saw a lot of unsafe sex going on inside the center, particularly older boys 
forcing younger boys to have sex with them. There were no condoms available; it’s 
mainly unprotected sex. I also saw a lot of sex happening between gay men and 
gay men, gay men and straight men, and straight men with younger boys, and 
straight men with lady boys.”
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Accounts of rape seem to be linked to older detainees forcing themselves on younger detain-
ees. It appears that longer-term residents are often put in positions of power to enforce CDTDC 
rules and regulations, but the position of power is clearly abused:
“The supervisors—people that have been in the center as residents a long time—
control the sleeping room and often force the younger boys to have sex with them. 
I saw the supervisors rape boys between the ages of 10 and 14.”
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In addition to allegations of rape, there were also references to the various forms of punish-
ment for infractions of CDTDC rules (including attempting to escape) and also to “calm” people 
who were undergoing withdrawal from drug use. Punishments were meted out by both guards 
and by supervisors:
“They always hit the people who are going through drug withdrawal, generally a 
group of ten ‘supervisors’ will hit and kick the person until they became scared and 
weak and calm down. If you go down quickly you won’t get beaten as badly, but if 
you take time to go down, they beat you until you bleed.”
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“They would attack anyone who tried to be strong or tried to escape. Ten men or 
so would beat them, kick them. The guards would use their shoes to beat them. 
I also saw the guards make people jump up and down like a frog until they were 
exhausted, became weak, and fell down.”
244
Treatment for drug use also appears absent or insufﬁcient:
 “Basically, unless your family pays 600,000 kip every 45 days [US$70] you will 
not receive any medication at all. If you are sick with a fever or anything, you 
have to write a letter to the guard, and the guard will decide if you can wait in the 
queue to see the health center. If you are really sick with clear signs of infection 
they may send you to the hospital or try and ﬁnd your family and tell them to 
take care of you.”
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In 2007, a US State Department report noted that the government of Laos refused multiple 
requests from the International Committee of the Red Cross to establish a presence in Laos and 
monitor prison conditions; it has, however, provided the UN and some NGOs with access to some 
prisons and CDTDCs, but this access is strictly limited.246 The US State Department report goes 
on to say that while it is generally believed that the conditions of CDTDCs are better than condi-
tions in prison, “the conditions are nevertheless spartan, lengths of detention indeﬁnite and the 
government does not permit regular independent monitoring.”247 
The head of the UNODC mission in Laos, Leik Boonwaat, said: 
“My own observation is that compared to a few years back, the authorities in the 
drug treatment centers in Laos are becoming more open and transparent, and this 
is mainly due to quiet diplomatic efforts including repeated visits and participation 
by treatment staff in various training and study visits organized by UNODC and 
other partners.”
248
Accounts from those recently released, however, indicate that the CDTDCs have far to go.
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Release and Recidivism 
As in Thailand and Cambodia, there remain serious concerns about the effectiveness of the 
CDTDCs in Laos to treat, rehabilitate, and prevent recidivism among methamphetamine users. 
A staff member from Somsagna Drug Rehabilitation Center notes that “about 70 percent 
of the people in Somsagna Drug Rehabilitation Center have been in here before; most of them 
relapse.”249 More formal evaluation of relapse either has not been done or has not been docu-
mented. While UNODC has worked with the government to improve data and information col-
lection about narcotics seizures and arrests,250 this has not yet developed into improved data on 
effectiveness of CDTDCs, with staff noting that rates of relapse are difﬁcult to track.251 It is clear 
that the government has responded to treatment failure by extending terms of detention: an indi-
vidual admitted to Somsagna Drug Rehabilitation Center for a second time will spend at least one 
year in detention (initial terms are six months) and, upon a third admittance, the period will be 
extended to two years.252 Dr. Chantravady is adamant that the CDTDCs in Laos have to improve:
“They need to follow up, and there needs to be a community network to help them 
after a release.”
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Those recently released from Somsagna Drug Rehabilitation Center commented that the 
center acted as a barrier to drug use because it removed people from a drug-using environment, 
but as soon as people left, they would return to their old social environments and would use 
methamphetamine again.
“The treatment is ineffective. All they do is try and make you not want to come 
back to the center. It doesn’t stop you using drugs because as soon as you return to 
your outside environment you will use again. They don’t deal with your addiction, 
and they don’t help you change your behavior.”
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Proliferation of the Compulsory Drug Treatment/
Detention Centers
In ongoing efforts to appeal to the international community for assistance in dealing with its 
country’s methamphetamine use, Minister Srithirath stated that Laos has reached a critical tipping 
point, and that the assistance of international donors is needed to ensure that the balance moves in 
the right direction.255 It is unclear what sort of balance or the direction to which Minister Srithirath 
refers, but the international donor community has responded to his calls for assistance and as a 
result, Laos has eight CDTDCs all built with bilateral donations. Despite enormous international 
funding for ongoing opium eradication, alternative development and the construction of CDTDCs, 
Minister Srithirath continues to ask the international donor community for further assistance: 
“We are concerned at the lack of resources to address the problem of 
methamphetamine and heroin abuse and alarmed at the emerging problem of 
injecting drug users in certain border areas.”
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The international bilateral donor community active in funding projects to combat illicit 
drugs in Laos is spearheaded by the Mini Dublin Group.257 In Laos, the Mini Dublin Group is 
very active: the embassies of Australia and Japan share a rotating chairmanship and ambassadors 
from the US, Germany, Japan, Australia, Singapore, and Swedish Charges d’Affairs are involved 
in regular meetings and site visits in Laos. The meetings and site visits are often organized and 
facilitated by UNODC and LCDC.
 Despite the concerns of academics, NGOs, individual ambassadors, and other observers 
of the government’s drug policy, the Mini Dublin Group continues to strike a positive tone: “The 
Mini Dublin Group was very impressed with progress. They saw for themselves how appropriate 
technology was providing a sustainable alternative to opium production and improving liveli-
hoods.”258 Concerns about the lack of evidence-based drug treatment, implications for the spread 
of infectious diseases, poor sanitary and hygienic conditions, lack of trained staff, and allegations 
of food shortages and human rights abuses have not been reﬂected in the work of the group. But 
in fact they and other countries continue to give bilateral donations to build more CDTDCs. 
In 2001, the then Chairman of the LCDC gave a speech to the Vientiane Mini Dublin Group 
in which he was pleased to inform that “with UNDCP assistance the construction of the ﬁrst 
Detoxiﬁcation Center for amphetamine-type stimulant addicts has already started and expected 
to be completed in the ﬁrst half of next year.”259 The US Embassy in Laos contributed to the 
renovation of Somsagna Drug Rehabilitation Center in 2001, and they recently spent US$32,000 
on renovating and furnishing a new women’s rehabilitation facility in the same grounds. The 
US Embassy in Laos anticipates that this will afford young, female methamphetamine users the 
opportunity to complete their full rehabilitation, lasting up to six months, in a secure residential 
environment.260 In dedicating the new facility, the US ambassador remarked that: 
“Those of you who are receiving treatment are the fortunate ones. You have the 
chance to resume and rebuild your lives. The purpose of building this center 
was not just to improve living conditions. The real purpose is to help you—the 
patients—be better prepared to regain the control of your own lives that yaa baa 
took away from you. As you know, this women’s rehabilitation center will allow 
you to return to your homes and communities with skills you will need for success: 
to acquire new job skills.”
261
 
At this stage, the effectiveness of the program at the women’s facility in Somsagna Drug 
Rehabilitation Center has not been evaluated, nor have the living conditions or vocational training 
programs.
The US has also provided ﬁnancial support for the construction of other centers. In February 
2005, the US Embassy’s bilateral counter-narcotics program provided US$600,000 for the con-
struction of a new 100-bed CDTDC in Savanakhet Province. A US State Department report notes 
that the center demonstrates the outstanding cooperation between the governments of Laos and 
the United States on demand reduction, and that the CDTDC is a model for future facilities and 
stands as an example of what cooperation between the two countries can achieve.262 The purpose 
of the CDTDC is to “treat drug addicts, especially those addicted to yaabaa.” The US Embassy said 
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it would work with UNODC to provide training to provincial medical staff of the CDTDC.263 In 
addition, the US Embassy is preparing to ﬁnance a smaller CDTDC in Vientiane Province, about 
70 kilometers from the capital.264 
Linthong Phetsavan, Head of the Permanent Secretariat of LCDC, acknowledged the inter-
national support and ﬁnancing of the CDTDCs at the 26th Meeting of the ASEAN Senior Ofﬁcials 
on Drug Matters (ASOD) held in Singapore in September 2005: 
“The construction of other Treatment and Rehabilitation Centers in Savanakhet 
and Champasak respectively, as part of assistance from the government of Thailand 
and the United States of America, is nearly completed. Hopefully the handover 
ceremony of the center will be held later this year. I am also pleased to inform 
you that China has agreed to provide ﬁnancial support for the construction of 
Treatment and Rehabilitation Center in Oudomxay Province whereby Vietnam 
will provide ﬁnancial support for the construction of another center in Vientiane 
City.”
265
In December 2005, Thailand co-chaired the handover ceremony for the “Treatment and 
Rehabilitation Center” located 21 km out of Pakse in Champasak Province, for which it had con-
tributed about US$650,000 for construction and medical supplies;266 the center ofﬁcially opened 
in 2007. Thailand’s ONCB notes that the CDTDC was “to be … the symbol …of the 55th anniversary 
of Thai-Laos Diplomatic Protocol as well as the cooperation on drugs control between the two 
countries.”267 
China funded the redesign of a CDTDC in Oudomxay in 2007. This new design was built 
to allow for its multipurpose functioning: it serves as the ofﬁce of the Provincial Commission for 
Drug Control in Oudomxay, as a CDTDC, and as an ofﬁce for a joint project between UNODC 
and United Nations Industrial Development Organization.268 In 2007, the government of Brunei 
contributed to the construction of two smaller CDTDCs in Sayaburi.269 Some of these CDTDCs 
operate under the provincial health authorities and some are under the Minister of Interior.
According to the provincial chief of the LCDC in Luang Prabang, Bounheuang Bulyaphol, 
the Japan International Cooperation Agency recently contributed US$86,000 to build two new 
buildings and a new 3-meter-high by 1.5-km-square wall in a redevelopment of an opium detoxiﬁ-
cation center in Luang Prabang. He was however skeptical about whether the new facility would 
be big enough:
“There are an estimated 5,000 yaba users in Luang Prabang, we do not have 
enough resources, and this drug treatment center can only accommodate 150 users 
per year, 50 inmates at any one time.”
270
 
Table 1. International ﬁnancial support for CDTDCs in Laos 2001–2008
Year Location International Support USD amount
2001 Vientiane UNDCP supports the ﬁrst detoxiﬁcation center for 
amphetamine-type stimulants users in Laos
Unknown
2001 Vientiane US Embassy contributes to renovation 
of Somsagna
Unknown
2005 Savanakhet US Embassy funds building of CDTDC US$600,000
2005 Pakse Government of Thailand funds building of 
“Treatment and Rehabilitation” center 
US$650,000
2007 Oudomxay China funds redesign of a former opium 
detoxiﬁcation center 
Unknown
2007 Sayaburi Government of Brunei funds constructiuon 
of two small centers 
Unknown
2008 Luang Prabang Japan International Cooperation Agency 
funds renovations to center 
US$86,000
As of 2009, the expansion of the Somsagna Drug Rehabilitation Center model across the 
country has resulted in eight CDTDCs at various stages of completion, operation, and utilization.
Figure 7. The new Provincial Commission for Drug Control/UNODC/United Nations Industrial 
Development Organization project ofﬁce and CDTDC in Oudomxay (Laos)
Source: UNODC Laos country ofﬁce.
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Figure 8. Map of Laos showing eight CDTDCs, year 2009. There were none in 2000.
Source: http://www.mapsofworld.com/laos/laos-political-map.html
The government of Laos and its foreign partners continue to fund and promote this 
compulsory drug treatment system despite the fact that the effectiveness, either in terms of the 
long-term beneﬁts to the individual methamphetamine users detained in these settings, or to the 
wider community, has not been scientiﬁcally assessed. A US State Department report released 
in 2008 states, “Most existing treatment facilities are notably deﬁcient in staff proﬁciency and 
effective vocational training.”271 Michael Hahn, the former UNAIDS country representative in 
Laos adds that: 
“At the moment, on a country-wide level, the centers are operating well below 
capacity and lack training, equipment, medical supplies, or developed vocational 
training tools to adequately rehabilitate methamphetamine users.”
272
Leik Boonwaat notes 
“There are currently only four fully operational centers: The Somsagna Treatment 
and Rehabilitation Center with 800 patients, The Champasak Drug Treatment 
Center with about 20–30 patients, The Savanakhet Drug Treatment and 
Rehabilitation Center with about 20–30 patients, and the Oudomxay Drug 
Treatment and Rehabilitation Center with about 20–30 patients. The treatment 
facilities in Luang Prabang, Sayaburi and Phong Sali are not operational. Except 
for Somsagna all other centers are very much under-utilized and have the capacity 
to treat up to 200 patients each.”
273
The capacity of the centers to provide appropriate treatment has not been evaluated at this 
stage. In addition, Boonwaat acknowledges that, 
“Drug addicts who have committed a criminal offence would be put in the criminal 
justice correctional facilities to which we [UNODC] have no access.”
Of signiﬁcant concern is the fact that rapid expansion of other CDTDCs is being based on 
the Somsagna Drug Rehabilitation Center model and as one UNODC ofﬁcial commented:
“Somsagna and Pakse compulsory drug treatment centers with all their defects and 
limitations are far ahead of the rest of the country in trained staff and treatment. 
Somsagna is viewed as a model for other centers, but the legitimate criticisms of 
various stakeholders already indicates that it is at best, a deeply-ﬂawed model.”
274
Michael Hahn, also said: 
“Our government counterparts in [Laos] are well aware of the limitations of 
the centers, but are not aware at this stage of any real alternatives. What we 
need are well thought out, evidence-based, culturally relevant alternatives to the 
centers. If we can all work at providing these options, I am sure the [government 
of Laos] will consider community-based alternatives to these drug treatment 
centers. UNAIDS in Laos remains concerned by the operation of these centers 
both from the lack of any evidence-based drug treatment perspective and 
because of the implications for HIV transmission of keeping large numbers of 
people in a closed space, particularly since there are no condoms available.”
275
The LCDC and the government of Laos in general are increasingly aware of the need for 
a more effective approach and have indicated that they would like to develop different strategies 
that would better rehabilitate and reintegrate drug users. In fact the Laos government has stopped 
requesting donor money to build more centers as many of the centers built are empty.276 As in 
Thailand and Cambodia though, a punitive approach to detaining alleged drug users continues to 
thwart effective approaches.
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Figure 9. Somsagna Drug Rehabilitation Center
Source: Somsagna staff member.
 
Annex 1:  An Overview of 
Methamphetamine Abuse and 
Treatment in the International 
Literature
Trends in Methamphetamine Abuse
Methamphetamine abuse remains a signiﬁcant problem worldwide. The 2008 World Drug Report 
by the United Nations Ofﬁce on Drugs and Crime (UNODC) estimated that 24.7 million persons 
currently abuse amphetamine-type stimulants.277 The 2009 World Drug Report estimated that 
somewhere between 16 million and 51 million people aged between 15 and 64 used some form 
of amphetamine-type stimulant in 2007.278 Methamphetamine constitutes the most frequently 
abused amphetamine-type stimulant,279 accounting for approximately 65 percent of the total or 
nearly 16 million individuals, which equals or exceeds the number using cocaine or opiates.280 
Southeast and East Asia currently represent the epicenter for methamphetamine production, traf-
ﬁcking, and consumption. 
The methamphetamine epidemic began in the late 1990s and peaked in 2000–2001. Recent 
evidence suggests increases in trafﬁcking and use in the Mekong Region, along with increases in 
large-scale production in Cambodia, Indonesia, Malaysia, and elsewhere.281 
Data collected by the Drug Abuse Information Network for Asia and the Paciﬁc (DAINAP) 
reveals methamphetamine as among the top three most common drugs of abuse in 12 of 13 
countries surveyed, while six (including Thailand, Laos, and Cambodia) ranked methamphet-
amine as the leading drug of abuse.282 While some Southeast Asian countries, such as Thailand, 
have reported stabilization or a decrease in rates of methamphetamine consumption, the overall 
prevalence is among the highest in the region. There has also been an increase in the use of the 
crystalline form of methamphetamine known as “ice.” Laos and Cambodia have reported increases 
in overall consumption of methamphetamine as well as a small but increasing prevalence of the 
use of ice.283
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Implications of Methamphetamine Use on Individual 
Health and Social Outcomes
Methamphetamine is easily synthesized, has high central nervous system penetration due to its 
lipophilic chemical structure, and produces both an immediate and lasting euphoric high, owing 
to its relatively long half-life. Such factors combine to make methamphetamine widely available, 
abused, and highly addictive. Methamphetamine abuse has short- and long-term health conse-
quences, some of which are unique to methamphetamine compared with other amphetamine-type 
stimulants, such as cocaine, and other commonly abused drugs in the region, such as opiates. 
Research suggests that methamphetamine users are more likely than abusers of other substances 
to encounter law enforcement ofﬁcers.284, 285 Indeed, more than 75 percent of drug-related arrests 
in Thailand, Cambodia, and Laos involved methamphetamine.286 From a public health perspective, 
the high coincidence of methamphetamine abuse and law enforcement involvement necessitates 
a ﬁrm understanding of the health effects of methamphetamine abuse, their acute management, 
and long-term treatment by health providers, community-based organizations working with meth-
amphetamine users, and law enforcement ofﬁcials.
Short-term Effects of Methamphetamine Abuse
Research in animal models suggests that the biochemical target of methamphetamine is presyn-
aptic dopaminergic transporters in the brain.287 Amphetamine-type stimulants promote increased 
release, and to a lesser extent, decreased reuptake of dopamine as well as other neurotransmit-
ters.288 The overall effect is a marked sympathetic (“ﬁght or ﬂight”) response with increases in 
heart rate, respiratory rate, body temperature, papillary dilation, and excessive sweating. In addi-
tion to physiologic changes, methamphetamine-induced release of neurotransmitters produces 
euphoria, which, unlike the shorter-lasting high of cocaine, can persist from eight to 12 hours 
and is accompanied by feelings of increased energy, curiosity, and interest in the surrounding 
environment; increased sexuality and desire; heightened attentiveness; and decreased anxiety.289
Methamphetamine tolerance develops gradually through various hypothesized neuro-
toxic290 and immunologic291 mechanisms that deplete neurotransmitters and shorten the dura-
tion of euphoric effects. During this period users typically engage in progressive dose-escalation, 
switch to more rapid routes of administration (e.g. inhalation or intravenous) and begin binging, 
characterized by repeated administration in response to drastic changes in mood (“binge-crash” 
cycle) that can last up to several days.292 Dose-escalation has important medical consequences, as 
most acute complications of methamphetamine abuse are dose-dependent and the transition to 
injectable forms of methamphetamine increases the risk of blood-borne infections such as HIV, 
hepatitis C, and sepsis. 
Although the physiologic effects of methamphetamine intoxication can produce marked 
cardiovascular, neurological, and metabolic effects, potentially causing myocardial infarction, cere-
bral hemorrhage, aortic dissection, arrhythmias, seizures, and hyperthermia, the incidence of 
such complications is rare and lower relative to those caused by cocaine use.293 Studies in US and 
Australian emergency departments indicate methamphetamine users are more likely to present 
with psychological disturbances including agitated delirium or acute psychosis, suicidal ideation, 
and injury or assault related to methamphetamine use.294, 295, 296 In addition, a majority of cases 
were deemed to be of high acuity and one-third required sedation, but only a small proportion 
required admission for severe psychiatric or medical problems and overnight observation/sedation 
was sufﬁcient for an additional one-third of patients studied.297
Methamphetamine-induced acute psychosis is a recognized complication of methamphet-
amine intoxication. While research involving prisoners and psychiatric inpatients reveals preva-
lence rates of psychotic symptoms to be between 20 to 30 percent298, 299 studies in outpatient 
and emergency room populations suggest rates closer to 12 to 13 percent.300 One study found 
pre-existing psychiatric comorbidities to be 10 times that of the general population, but metham-
phetamine users remained three times more likely to experience psychotic episodes after adjusting 
for pre-existing illness. Furthermore, methamphetamine users are much more likely to experience 
psychotic symptoms relative to cocaine users301 and one-quarter of those with such symptoms also 
exhibit violent or hostile behaviors.302 Importantly, research not only indicates low prevalence 
of acute psychosis in community settings, but also that occurrence of such symptoms is associ-
ated primarily with heavy or chronic methamphetamine use and generally resolves spontaneously 
within hours or days.303
Long-term Effects of Methamphetamine Abuse
In addition to physical changes including a marked aging effect, weight-loss, and severe tooth 
decay (“meth mouth”), chronic methamphetamine abuse can lead to increased risk of psychiatric 
illness and neurocognitive deﬁcits.304, 305 Recent research in animal models and methamphetamine 
patients has focused on biochemical changes observed in the brain, particularly dopamine deple-
tion associated with chronic use. Studies have linked reductions in dopamine transporters with 
decreased performance in tests of cognitive and motor function.306
 
Functional imaging studies 
in the brains of former methamphetamine users demonstrate regrowth of these transporters; 
however, despite one to three years of abstinence, testing revealed persistent psychomotor impair-
ments.307 Other studies have shown prolonged deﬁcits among abstaining methamphetamine users 
with respect to social-cognitive functioning including depression, motivation, aggression, social 
isolation, and decreased prospective memory formation.308, 309 The presence of such long-term 
deﬁcits not only highlights the importance of early intervention with new methamphetamine 
users but also has implications for rehabilitative services designed for those suffering from meth-
amphetamine dependence.
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Methamphetamine Withdrawal Syndrome 
Much of what is known about withdrawal from methamphetamine is based on research involving 
patients recovering from cocaine addiction. Only a few prospective studies speciﬁc to methamphet-
amine withdrawal have been performed to-date. However, evidence suggests methamphetamine 
withdrawal differs from cocaine withdrawal in that the anergia and dysphoria is more severe. 
Unlike the marked physical symptoms associated with alcohol or opiate withdrawal, metham-
phetamine withdrawal syndrome is largely psychological, consisting of dysphoria, irritability, poor 
concentration, and sleep disturbance.310 The most comprehensive study of the natural history 
of methamphetamine withdrawal found a biphasic course: severe depressive symptoms peaked 
within the ﬁrst 24 hours of abstinence and returned to control levels by day seven; less severe 
symptoms of hypersomnolence, hyperphagia, anxiety, irritability, agitation, psychomotor retarda-
tion, poor concentration, tension, vivid dreams, and drug craving persisted throughout the sec-
ond and third weeks of abstinence.311 Although limited, relevant regional research312 describes a 
relatively mild withdrawal syndrome, consisting primarily of depressive psychological symptoms, 
with the most severe symptoms occurring during the ﬁrst hours of abstinence and largely resolv-
ing within one week.
Treatment of Methamphetamine Dependence 
Similar to studies of methamphetamine withdrawal syndrome, little randomized, controlled data 
exists evaluating the various treatment approaches to methamphetamine dependence. The most 
widely studied are cognitive-behavioral therapy, contingency management or contracting, multifac-
eted programs such as the Matrix Model, case management, Stepped-Approach, and group-tailored 
strategies.313, 314, 315, 316, 317 Emerging research seeks to develop pharmacologic interventions to replace 
or supplement psychological-behavioral treatment strategies. Several medications including anti-
depressants and stimulants have been tested in clinical trials with the goals of decreasing crav-
ings, improving treatment retention rates, substituting amphetamine, and increasing abstinence. 
Findings are preliminary, but bupropion, mirtazapine, baclofen, topiramate, and D-amphetamine 
have shown some beneﬁt in augmenting psychosocial outpatient therapy.318, 319, 320, 321
Annex 2: A Peer-based Network 
Trial with Methamphetamine 
Users in Chiang Mai, Northern 
Thailand
A Chiang Mai University and Johns Hopkins School of Public Health collaborative National 
Institute on Drug Abuse research project explored methods of reducing harm associated with 
methamphetamine use.322 The phase III randomized control trial was designed to assess the efﬁ-
cacy of a network-orientated peer intervention for methamphetamine use reduction and STI/HIV 
prevention among young methamphetamine users and their drug-using and sexual networks. 
The intervention arm of the trial received risk reduction counseling plus seven two-hour network-
orientated peer-educator sessions and a booster session. The control arm received risk reduction 
counseling and seven two-hour group sessions on life-skills training. 
While the study did not show a signiﬁcant difference between the control and interven-
tion arms of the study, participants in both arms of the study received information about the 
physiological and psychological effects of methamphetamine; harm reduction strategies; and STI 
information, testing, and treatment services. Both arms showed a signiﬁcant reduction in meth-
amphetamine use (Figure 1) and an increase in condom use (Figure 11) over time.323 
Outreach 
The outreach team was composed of young adults who were well versed in community issues, 
understood the culture of methamphetamine use, and could interact with both community lead-
ers and methamphetamine users alike. The outreach team was well funded, supportive, friendly, 
nonjudgmental, peer orientated, adaptable, and able to engage and interact with networks of 
methamphetamine users around the city.
  5 9
6 0   A N N E X E S
Service Provision
Both the intervention and control arms of the trial received equal access to services tailored to 
methamphetamine users. Both the intervention and control incorporated many aspects of harm 
reduction and were directly designed to address issues of harm associated with methamphetamine 
use, and were tailored toward issues that methamphetamine users themselves spoke of during the 
ethnographic phase. Aspects of service provision that both aimed to reduce harm associated with 
methamphetamine use and provide primary health care services included: 
• Information regarding the pharmacological and physiological effects of methamphet-
amine use;
• Methods to assist in the reduction of methamphetamine use and in reducing risk 
behaviors associated with its use; 
• In-depth information about prevention, treatment, and care of HIV/AIDS and other 
common STIs; 
• Free STI testing through urine and vaginal sample analysis for trichomoniasis, gonor-
rhea, and chlamydia, and free treatment for positive STI cases; and 
• Free and optional voluntary counseling and testing for HIV.
Community Integration and Stigma Reduction
The study worked with methamphetamine users and community leadership structures to reduce 
aspects of stigma and discrimination. The team facilitated sessions between methamphetamine 
users and the community and discussed the feasibility of conducting small community projects 
that would be undertaken by people in the study. Such projects were often simple but symbolic in 
supporting community strength and unity; for example, the young users would help garden the 
local grounds of the temple.
Partnerships with Law Enforcement
The study fostered cooperation with local law enforcement agencies. The relationship was carefully 
built by senior members of the research team and included regular discussions about the purpose 
and progress of the study and an in-principle agreement that no study participants would face 
interactions with law enforcement as a direct result of participating in the study. This included the 
“safe house” intervention site being given a permission to run activities with methamphetamine 
users without any interference from police. Furthermore, senior police were invited to community 
advisory board meetings. A strong partnership between the police and the research team was a 
feature of the study.
Figure 10. Mean proportion using methamphetamine at baseline and at 3-, 6-, 9-, and 12-month 
follow-ups by intervention assignment. Brackets at each time point show 95% conﬁdence 
intervals for the mean.
Figure 11. Mean proportion always using condoms at baseline and at 3-, 6-, 9-, and 12-month 
follow-ups by intervention assignment. Brackets at each time point show 95% conﬁdence 
intervals for the mean.
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Public Health Program
The Open Society Institute’s Public Health Program aims to build societies committed to inclusion, 
human rights, and justice, in which health-related laws, policies, and practices are evidence-based 
and reﬂect these values. The program works to advance the health and human rights of marginalized 
people by building the capacity of civil society leaders and organizations, and by advocating for 
greater accountability and transparency in health policy and practice. The Public Health Program 
engages in ﬁve core strategies to advance its mission and goals: grantmaking, capacity building, 
advocacy, strategic convening, and mobilizing and leveraging funding. The Public Health Program 
works in Central and Eastern Europe, Southern and Eastern Africa, Southeast Asia, and China.
International Harm Reduction Development Program
The International Harm Reduction Development Program (IHRD), part of the Open Society 
Institute’s Public Health Program, works to advance the health and human rights of people who 
use drugs. Through grantmaking, capacity building, and advocacy, IHRD works to reduce HIV, fatal 
overdose and other drug-related harms; to decrease abuse by police and in places of detention; 
and to improve the quality of health services. IHRD supports community monitoring and advocacy, 
legal empowerment, and strategic litigation. Our work is based on the understanding that people 
unwilling or unable to abstain from illicit drug use can make positive changes to protect their health 
and that of their families and communities. 

Methamphetamine use is a serious public health concern 
in Cambodia, Laos, and Thailand. Despite having policies 
that recognize addiction as a health problem, these 
governments are increasingly using law enforcement 
approaches that treat drug users as criminals rather than 
patients. This report examines the growing use of detention 
as “treatment” for methamphetamine users in the three 
countries. It examines the policies and practices that 
force people into detention centers, documents abuses 
and human rights violations occurring in the centers, 
and discusses the overall implications for individual and 
public health.
